UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2004
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 0-17995
ZIX CORPORATION
Texas
75-2216818
(State of Incorporation)
(I.R.S. Employer
Identification Number)
2711 North Haskell Avenue
Suite 2300, LB 36
Dallas, Texas 75204-2960
(Address of Principal Executive Offices)
(214) 370-2000
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Class | Outstanding at July 31, 2004 | ||||||
Common Stock, par value $.01 per share
|
31,926,652 | ||||||
INDEX
PART I-FINANCIAL INFORMATION
2
ZIX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
See accompanying notes.
3
ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
See accompanying notes.
4
ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY
(Unaudited)
See accompanying notes.
5
ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
See accompanying notes.
6
ZIX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
General
The accompanying condensed, consolidated financial statements of Zix
Corporation and its wholly owned subsidiaries (the Company) should be read in
conjunction with the audited consolidated financial statements included in the
Companys 2003 Annual Report to Shareholders on Form 10-K. These financial
statements are unaudited but have been prepared in the ordinary course of
business for the purpose of providing information with respect to the interim
periods. The Condensed Consolidated Balance Sheet at December 31, 2003 was
derived from the audited Consolidated Balance Sheet at that date which is not
presented herein. Management of the Company believes that all adjustments
necessary for a fair presentation for such periods have been included and are
of a normal recurring nature. The results of operations for the three and
six-month periods ended June 30, 2004 are not necessarily indicative of the
results to be expected for the full year.
The Company operates in a single industry segment, providing solutions
that protect, manage and deliver sensitive electronic information. These
solutions are grouped into two categories: Communications Protection and Care
Delivery Solutions. By offering two comprehensive sets of products and
services, the Company protects organizations from viruses and spam, provides
the management tools needed for Web access control and policy-driven email
encryption, and provides care delivery solutions for e-prescribing, e-lab
results, online doctor visits and e-consulting that enable physicians to
leverage technology for better patient care.
In 1999, the Company began developing and marketing products and services
that bring privacy, security and convenience to Internet users. ZixMail®, a
desktop solution for encrypting and securely delivering email, was first
commercially introduced in the first quarter of 2001. In 2002, the Company
began offering additional products. ZixVPM® (Virtual Private Messenger) is an
e-messaging gateway solution that provides company-wide privacy protection for
inbound and outbound email communications. ZixAuditor® is an assessment service
used to analyze email traffic patterns and monitor compliance with corporate
and regulatory policies. ZixPort provides a secure Web-messaging portal. In
2003, the Company introduced ZixWorks, a suite of fully managed hosted
services that enables users to send email securely and that protects
organizations from viruses, spam, inappropriate content and electronic attack.
In July 2003, the Company acquired substantially all of the operating
assets and the business of PocketScript, LLC (PocketScript), a privately-held
development stage enterprise that provided electronic prescription solutions
for the healthcare industry. This acquisition enabled the Company to expand its
services into care delivery solutions, specifically, the e-prescription
marketplace.
In September 2003, the Company acquired substantially all of the operating
assets and the business of Elron Software, Inc. (Elron Software), a
majority-owned subsidiary of Elron Electronic Industries Ltd. and a provider of
anti-spam, email content filtering and Web filtering solutions. This
acquisition enabled the Company to add a feature set to its anti-spam,
anti-virus, and email content filtering services while expanding its offerings
to include Web filtering. All of these solutions can now be offered on-premise,
fully hosted, or co-sourced (meaning a shared service offering).
In January 2004, the Company acquired substantially all of the operating
assets and the business of MyDocOnline, Inc. (MyDocOnline), a subsidiary of
Aventis Pharmaceuticals, Inc., the North American pharmaceuticals business of
Aventis SA. MyDocOnline offers, under the service names of Connect and Dr.
Chart®, a variety of Internet-based healthcare services and is a provider of
secure Web-based communications, disease management, and laboratory information
solutions. Through the acquisition, the Company believes it has acquired a
fully developed product and an installed base of physicians already using the
Dr. Chart® products.
7
Operating in emerging markets involves risks and uncertainties, and there
are no assurances that the Company will be successful in its efforts.
Successful growth of an early stage enterprise is costly and highly
competitive. The Companys growth depends on the timely development and market
acceptance of its products and services. In 2003 and the first half of 2004,
the Company has incurred significant operating losses and the use of cash
resources has continued at a substantial level. The Company anticipates further
operating losses in 2004. At June 30, 2004, the Companys cash and marketable
securities totaled $26,177,000. The Companys future cash requirements depend
primarily on the timing and magnitude of cash flows generated from new customer
orders. Cash flows will also be impacted by capital expenditure requirements,
resources devoted to the additional development of products and services,
resources devoted to services deployments and sales and marketing.
The Company may need to raise additional funds in the future
to sustain its operations or initiate reductions in operating expenses, or
both. The Company will continue to consider various capital funding
alternatives to strengthen its financial position. These capital funding
alternatives could involve one or more types of equity securities, including
convertible debt, common or convertible preferred stock and warrants to acquire
common or preferred stock. Such equity securities could be issued at or below
the then-prevailing market price for shares of the Companys common stock. The
Company currently has no existing credit facilities. There can be no assurances
that the Company will be able to raise additional capital on satisfactory terms
if and when needed.
Receivables, net
Receivables, net consists of the following:
The reduction for deferred revenue represents future customer service or
maintenance obligations that have been billed to the customer but remain unpaid
as of the date indicated. Deferred revenue on the Companys condensed
consolidated balance sheets represent future customer service or maintenance
obligations that have been billed and collected as of the respective balance
sheet date.
Intangible Assets
At
June 30, 2004, the Companys intangible assets, subject to
amortization,
were comprised of the following, which resulted from the third quarter 2003
acquisitions of PocketScript and Elron Software and the first quarter 2004
acquisition of MyDocOnline:
Amortization expense relating to intangible assets subject to amortization
totaled $472,000 and $889,000 in the three and six months ended June 30, 2004,
respectively. There was no amortization expense in the three or six months
ended June 30, 2003. The expected future amortization expense is as follows:
8
Stock Compensation
As permitted by Statement of Financial Accounting Standards No. 123,
Accounting for Stock-Based Compensation (SFAS 123), the Company accounts
for stock-based compensation plans under the provisions of Accounting
Principles Board Opinion No. 25, Accounting for Stock Issued to Employees
(APB 25) and related interpretations. SFAS 123 encourages adoption of a
fair-value based method for valuing the cost of stock-based compensation;
however, it allows companies to continue to use the intrinsic value method
under APB 25 and disclose pro forma results and earnings per share in
accordance with SFAS 123. Had compensation cost for the Companys stock-based
compensation been determined consistent with the fair value method of SFAS 123,
the Companys net loss and loss per common share would have been as follows:
Loss per common share
The amounts presented for basic and diluted loss per common share in the
accompanying statements of operations have been computed by dividing the losses
applicable to common stock by the weighted average number of common shares
outstanding. A reconciliation of the numerator of basic and diluted net loss
per share is provided as follows:
The two presentations are equal in amounts because the assumed exercise of
common stock equivalents would be anti-dilutive, because a net loss was
reported for each period. The accretion of preferred stock dividends shown
above pertain to the Series A and Series B convertible preferred stocks, which
were issued and outstanding during that period. Common stock equivalents that
have been excluded from the computation of diluted loss per common share
consist of the following:
2. Business Acquisitions and Related Transactions
MyDocOnline, Inc.
On January 30, 2004, the Company acquired substantially all of the
operating assets and the business and assumed certain liabilities of
MyDocOnline, a subsidiary of Aventis Pharmaceuticals, Inc., the North American
pharmaceuticals business of Aventis SA and a leading provider of secure
Web-based communications, disease management, and laboratory information
solutions, pursuant to an asset purchase agreement. The consideration for the
net assets acquired consisted of 583,411 shares of the Companys common stock.
The components of the aggregate cost of the acquisition are as follows:
9
The fair market value of the Companys common stock for financial
accounting purposes was calculated using the five day average of the closing
prices on the date that the terms were agreed to and announced and the two trading days before and after
such date.
The Company is in the process of obtaining third-party valuations of
certain intangible assets; thus, the allocation of the purchase price is
subject to refinement. The cost of the acquisition of MyDocOnline has been
allocated, on a preliminary basis, to in-process research and development and
to the identified assets and liabilities acquired with the remainder recorded
as goodwill, based on estimates of fair values as follows:
The value of the acquired developed technology, customer relationships and
in-process research and development was determined by discounting the estimated
projected net cash flows to be generated from the related assets using a
discount rate of 31%. In-process research and development was immediately
expensed. Values assigned to developed technology and customer
relationships are being amortized to cost of revenues and selling, general and administrative
expenses, respectively, on a straight-line basis over three to five years from
the acquisition date.
The results of operations of MyDocOnline are included in the Companys
results of operations from the date of closing. Revenues from the acquired
business of MyDocOnline for the six-month period ended June 30, 2004 totaled
$276,000.
Promissory Note Payable and Warrants Issued to Aventis
Concurrent with the MyDocOnline acquisition, at closing Aventis, Inc.
(Aventis) loaned the Company $3,000,000 due March 15, 2007, which loan bears
interest at an annual rate of 4.5%. The loan is evidenced by a secured
promissory note. Interest on the note is payable only in services provided by
the Company to Aventis unless there is an event of default. The principal
portion of the note is payable in either cash or shares of the Companys common
stock, based on the then current value of such shares, at the option of the
Company and may be prepaid by the Company at any time without penalty.
Additionally, at Aventis discretion and after the $4,000,000 customer deposit
from Aventis under the Master Services Agreement described below has been
consumed, the principal portion of the note may be paid in the form of
additional services provided to Aventis by the Company pursuant to the terms of
such services agreement. Should Aventis choose to not have the note paid in the
form of services, the Company is required to pay the note in cash or stock at
maturity, however, at an amount equal to 90% of the face amount of the loan, or
$2,700,000, which the Company considers its minimum liability.
Concurrent
with the issuance of the note payable to Aventis, the Company issued
warrants to purchase 145,853 shares of ZixCorp common stock. The exercise
price and term of the warrants is $13.01 per share and three years, respectively.
Based on relative fair values at time of issuance, the loan proceeds were
allocated to the note payable of $1,525,000 and to the warrants of $1,475,000.
The fair value of the warrants was calculated using the Black-Scholes pricing
model. The fair value of the note was calculated based on an estimated
interest rate that the Company could obtain independently. The resulting
discount of $1,175,000 on the minimum liability of $2,700,000 represents
unamortized debt discount which is being amortized to interest expense over the
three year loan life to yield an effective interest rate of 11%. This rate approximates a cost of borrowing valuation estimated by an
independent valuation company. The loan is secured by the
Companys property and equipment and accounts receivable pursuant to a security
agreement.
10
Customer Deposit from Aventis
A Master Services Agreement was entered into with Aventis for $4,000,000
on the same date as the MyDocOnline acquisition for the performance, by the
Company, of various future services. The services are to be delivered in
minimum amounts of $1,000,000, $1,000,000 and $2,000,000 prior to the first,
second and third calendar year anniversary dates of the acquisition closing,
respectively. The services will be defined on an ongoing basis over the life of
the agreement and valued in accordance with similar pricing for similar
services rendered to other customers. Aventis paid the $4,000,000 upon
execution of the Master Services Agreement.
The Companys services, to be provided to Aventis, have not yet been
fully defined; therefore, the liability has been recorded as a customer deposit. As
the services are defined and priced in individual project agreements, the value
of the defined element will be reclassified to deferred revenues and then
recognized as revenue in accordance with applicable revenue recognition
criteria. Aventis will forfeit any unused amounts annually if services are not
requested by Aventis in accordance with the terms of the Master Services
Agreement. The Company is required to
return to Aventis any unused portion of the deposit only in the event of
material breach of the contract by the Company, in the event the Company or a
party employed or engaged by the Company is debarred pursuant to the Generic
Drug Enforcement Act of 1992 or similar state, local or foreign law, in the
event ZixCorp files for bankruptcy, or in the event of force majeure. The
Company believes that it is unlikely any of these events will occur. The
Companys obligations associated with the Master Services Agreement are secured
by a first priority lien on the Companys property and equipment and accounts
receivable. As of June 30, 2004, the Company has provided
$40,000 of services to Aventis under this Master Services Agreement.
Elron Software, Inc.
On September 2, 2003, the Company acquired substantially all of the
operating assets and the business of Elron Software, a majority-owned
subsidiary of Elron Electronic Industries Ltd. Elron Software develops,
markets, licenses, supports and maintains computer software products that
provide anti-spam, email content filtering and Web filtering solutions. The
consideration for the acquisition totaled $7,471,000 and consisted of 1,709,402
shares of the Companys common stock with a fair market value of $6,333,000, a
5.75% convertible note for $1,000,000 and acquisition related transaction costs
of $138,000. In November 2003, the note and related accrued interest were
converted by the holder into 262,454 shares of the Companys common stock at a
conversion price of $3.86 per share.
PocketScript, Inc.
On July 22, 2003, the Company acquired substantially all of the operating
assets and the business of PocketScript, a privately-held development stage
enterprise that provides electronic prescription solutions for the healthcare
industry. The consideration for the acquisition totaled $1,457,000 and
consisted of 362,903 shares of the Companys common stock with a fair market
value of $1,386,000, a $50,000 cash payment and acquisition related transaction
costs of $21,000. PocketScripts historical operating results were
insignificant compared to the Companys historical operating results.
Pro Forma Information
The following unaudited pro forma information presents the Companys
results of operations as if the acquisitions of MyDocOnline and Elron Software
had occurred as of January 1, 2003. The pro forma information has been prepared
by combining the results of operations of the Company, MyDocOnline and Elron
Software, with adjustments to record the amortization of intangible assets
resulting from the allocation of the cost of the acquisitions, to eliminate the
historical expenses of MyDocOnline and Elron Software for amortization of
intangible assets that were excluded from the assets acquired by the Company
and to eliminate the historical interest expense on the intercompany debt of
MyDocOnline and Elron Software, which was excluded from the liabilities
acquired by the Company. Adjustments related to the MyDocOnline
acquisition include the recording of interest expense on the promissory
note payable to Aventis. In addition, adjustments related to the Elron Software
acquisition include the elimination of historical expenses for stock
compensation, the recording of interest expense and adjustments to recognized
revenues resulting from the application of purchase accounting. The pro forma
information does not purport to be indicative of what
11
would have occurred had
the acquisition occurred as of January 1, 2003, or the results of operations
that may occur in the future.
3. Conversion/Redemption of Convertible Preferred Stock
In September 2002, the Company received total proceeds of $8,000,000 in
exchange for shares of two newly created series of convertible preferred stocks
and related warrants to purchase 709,528 shares of the Companys common stock.
Beginning in September 2002 and concluding in September 2003, all of the
convertible preferred stocks were redeemed by the Company or converted by the
investors into 2,166,977 shares of the Companys common stock. During the
three-month and six-month periods ending June 30, 2003, the Company recorded
preferred stock dividends of $473,000 and $967,000, respectively. At June 30,
2004, of these warrants issued in September 2002, warrants to purchase 514,408
shares of the Companys common stock remained outstanding. These warrants have
an exercise price of $4.42 per share and expire in 2006.
4. Revenues and Significant Customers
The Company develops, markets, licenses and supports computer software
products and services. For revenue purposes, the Companys products can be
placed into several key revenue categories where each category has similar
revenue recognition traits; Communications Protection subscription based
services, perpetual software license sales, the PocketScripts e-prescribing
product, various transaction fees and professional services. Under all
categories, the Company recognizes revenue after all of the following occur:
persuasive evidence of an arrangement exists, delivery has occurred or services
have been rendered, a right or return does not exist, the price is fixed and
determinable, and collectability is reasonably assured. In the event the
arrangement has multiple elements with delivered and undelivered elements, the
delivered elements are recognized only when vendor-specific objective evidence
of fair value (VSOE) exists to allocate the fair value of the total fees to the
undelivered elements of the arrangement.
Communication Protection subscription based services include products such
as ZixMail, ZixVPM, ZixPort, ZixWorks, anti-spam signatures subscription,
anti-virus subscriptions and certain products acquired from MyDocOnline. The
Companys Communications Protection subscription services include delivering
licensed software and providing customer support and secure electronic
communications throughout the subscription period. The customer is often
provided an appliance during the subscription period with pre-installed
software or contractually subscribes to a data center resident service. In a
subscription service, the customer does not own a perpetual right to a software
license, but is instead granted the use of that license during the period of
the subscription. Subscriptions to date have generally been annual
non-refundable contracts. Some of the contracts have automatic renewal
provisions. The subscription period begins on the date specified by the
parties. Revenues from subscription services are recorded as service revenue as
the services are rendered. Subscription fees received from customers in advance
are recorded as deferred revenue and recognized as revenues ratably over the
subscription period.
The Company sells anti-spam filtering, email content filtering, Web
filtering solutions and certain products acquired from MyDocOnline to customers
under perpetual licensing arrangements. These perpetual software licenses are
normally sold as part of multiple element arrangements that include annual
maintenance, and may include implementation or training services. Where VSOE
has not been established for undelivered elements, revenue for all elements is
deferred until those elements have been delivered or their fair values have
been determined. However, if VSOE is determinable for all of the undelivered
elements, and the undelivered elements are not essential to the delivered
elements, the Company will defer recognition of the fair value related to the
12
undelivered elements and recognize as revenue the remaining portion of the
arrangement through application of the residual method. Evidence of VSOE for
implementation and training services associated with the anti-spam, email
content filtering and Web filtering arrangements is based upon standard
billing rates and the estimated level of effort for the individuals expected to
perform the related services. Installation and training revenues are recognized
as the services are rendered. The Company establishes VSOE for maintenance
based upon contract renewal rates. The Company recognizes maintenance revenue
over the term of the maintenance agreement, generally one year.
The Company recognizes revenue on the PocketScript e-prescribing service
as a multiple element arrangement with separate units of accounting. VSOE is
determined for the undelivered elements, and the residual value is assigned to
the device and is recognized upon installation of the device and service at an end-user
location. Installation is determined by physical delivery of a functioning
product. The fair values of the undelivered elements relate to ongoing
services and are recognized ratably over the period of the service. The
Company establishes VSOE for the service elements based upon contract renewal
rates or fair market values if the element is commonly sold by others.
Some of the Companys services incorporate a transaction fee per event
occurrence or when predetermined usage levels have been reached. These fees are
recognized as revenue when the transaction occurs. The Company contracts with
customers to provide certain profession services as stand alone offerings. The
Company recognizes these as revenue as the services are rendered and utilizes
the percentage of completion method when appropriate.
Service revenues for the first half of 2003 included $234,000 per quarter
(28% for the six-month period) resulting from the pro-rata recognition of
certain minimum payments associated with the Companys marketing agreement with
Entrust, Inc. (Entrust). These minimum payments aggregating $3,750,000 were
being recognized as revenue ratably over the four-year maximum service period
ending in December 2005. Entrust paid the Company a $1,000,000 guaranteed
minimum payment in January 2003. In July 2003, the Company and Entrust mutually
agreed to terminate the marketing agreement, because the marketing agreement,
as structured, no longer served their respective business interests. In
connection with the termination of the marketing agreement, Entrust paid the
Company $700,000 and the scheduled minimum guaranteed payments to have been
made in 2004 and 2005, totaling $2,750,000, were cancelled.
13
ITEM 2.
MANAGEMENTS DISCUSSION AND ANALYSIS OF
Overview
The Company operates in a single industry segment, providing solutions
that protect, manage and deliver sensitive electronic information. These
solutions are grouped into two categories: Communications Protection and Care
Delivery Solutions. By offering two comprehensive sets of products and
services, the Company protects organizations from viruses and spam, provides
the management tools needed for Web access control and policy-driven email
encryption, and provides care delivery solutions for e-prescribing, e-lab
results delivery, online doctor visits and e-consulting that enable physicians
and patients to leverage technology for better patient care.
In 1998 and prior years, the Company provided systems and solutions for
the intelligent transportation, electronic security and other markets. The
Company sold all of its operating units in 1998 and began evaluating new
Internet-related business opportunities. The Company perceived a need for
products and services to bring privacy, security and convenience to Internet
communications and since January 1999, the Company has been developing and
marketing products and services that bring privacy, security and convenience to
Internet users. In the first quarter of 2001, the Company first
introduced ZixMail®, a desktop solution for encrypting and
securely delivering email, and
began focusing its sales and marketing efforts toward the business market. In
2002 and 2003, the Company significantly expanded its portfolio of commercial
products and services and rebuilt its sales and marketing work force under new
executive leadership. The expanded communications protection portfolio of
commercial products and services included ZixVPM (Virtual Private Messenger),
an e-messaging gateway solution that provides company-wide privacy protection
for inbound and outbound email communications, ZixAuditor, an assessment
service used to analyze email traffic patterns and monitor compliance with
corporate and regulatory policies, ZixPort, a secure Web-messaging portal, and
ZixWorks, a suite of fully managed hosted services that enables users to send
email securely and that protects organizations from viruses, spam,
inappropriate content and electronic attack. Further, the Company has targeted
the healthcare sector, where the legislated mandates of the Health Insurance
Portability and Accountability Act, a 1996 law that requires Protected Health
Information to be safeguarded over open networks, are driving demand. The
privacy regulations for this law took effect in April 2003 and the security
regulations are scheduled to go into effect in early 2005.
In July 2003, the Company acquired substantially all of the operating
assets and the business of Ohio-based PocketScript, LLC (PocketScript), a
privately-held development stage enterprise which provides electronic
prescription solutions for the healthcare industry. This acquisition enabled
the Company to expand its services into care delivery solutions, specifically,
the e-prescription marketplace, which is expected to grow significantly as more
physicians are leveraging technology in delivering care, coupled with the fact
that the number of prescriptions written annually in the United States
continues to increase and confidence in the accuracy of written
prescriptions declines. In September 2003, the Company acquired substantially
all of the operating assets and the business of Elron Software, Inc. (Elron
Software or Elron), a majority-owned subsidiary of Elron Electronic
Industries Ltd. and a provider of anti-spam, email content filtering and Web
filtering solutions. This acquisition enabled the Company to add a feature set
to its anti-spam, anti-virus, and content filtering services while expanding
its offerings to include Web filtering. In January 2004, the Company acquired
substantially all of the operating assets and the business of MyDocOnline, Inc.
(MyDocOnline), a subsidiary of Aventis Pharmaceuticals, Inc., the North
American pharmaceuticals business of Aventis SA. MyDocOnline offers a variety
of Internet-based healthcare services and is a provider of secure Web-based
communications, disease management, and laboratory information solutions.
PocketScript, Elron Software and MyDocOnline have incurred operating losses in
recent years.
The foundation of the Companys business model is centered around the
financial leverage expected to be generated by its various subscription and
transaction based revenues that are believed to be predominantly recurring in
nature and an efficient cost structure for its secure data center operations,
the core of which is expected to remain relatively stable. Subscription fees
are generally expected to be collected at the beginning of the subscription
period either on an annual or quarterly basis and are recognized as revenue on
a prorated basis over the length of the subscription period.
14
Operating in emerging markets involves risks and uncertainties, and there
are no assurances that the Company will be successful in its efforts.
Successful growth of an early stage enterprise is costly and highly
competitive. The Companys growth depends on the timely development and market
acceptance of its products and services. In 2003 and the first half of 2004,
the Company and its recent acquisitions have incurred significant operating
losses and the use of cash resources has continued at a substantial level. The
Company anticipates further operating losses in 2004.
Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in
accordance with accounting principles generally accepted in the United States
requires the Companys management to make estimates and assumptions that affect
the amounts reported in the Companys consolidated financial statements and
accompanying notes. Actual results could differ from these estimates and
assumptions. Critical accounting policies and estimates are defined as those
that are both most important to the portrayal of the Companys financial
condition and results and require managements most subjective judgments. The
Companys most critical accounting policies and estimates are described below.
Long-Lived
and Other Intangible Assets
The
Companys long-lived assets, comprised of identified intangibles and property and
equipment aggregating $10,648,000 or 22% of total assets at June 30, 2004, are
periodically reviewed for impairment, by comparing the carrying value of the
asset with its estimated fair value. The potential impairment is measured based
on a projected discounted cashflow method, using a discount rate that is
considered to be commensurate with the risk inherent in the Companys current
business model. Assumptions are made with respect to future net cash flows
expected to be generated by the related asset. An impairment charge would be
recorded for an amount by which the carrying value of the asset exceeded the
discounted projected net cash flows.
Goodwill, totaling $9,119,000 or 19% of total assets at June 30, 2004,
represents the cost in excess of fair value of net assets acquired in the
September 2003 acquisition of Elron Software and the January 2004 acquisition
of MyDocOnline. The Company will evaluate its goodwill for impairment annually
as of October 1, beginning in 2004, or when there is reason to believe that the
value has been diminished or impaired. Evaluations for possible impairment are
based upon a comparison of the estimated fair value of the business unit to
which the goodwill relates to the sum of the carrying value of the assets and
liabilities of that unit. The fair values used in this evaluation are estimated
based upon discounted future cash flow projections for the unit and market
values of comparable businesses where available. An impairment is deemed to
exist if the net book value of the unit exceeds its estimated fair value.
Future changes made to the current estimates or assumptions, including
such factors as order volumes and price levels, life spans of purchased
technology, continuity of acquired customers, alternative uses for property and
equipment and levels of operating expenses, could result in an unanticipated
impairment charge from the write-down of the Companys long-lived assets or
goodwill.
Deferred Tax Assets
As required by Statement of Financial Accounting Standards No. 109, the
Company recognizes deferred tax assets on its consolidated balance sheet if it
is more likely than not that the subject net operating loss carry forwards
and unused tax credits will be realized on future federal income tax returns.
At June 30, 2004, the Company continued to provide a full valuation allowance
against accumulated U.S. deferred tax assets of approximately $78 million,
reflecting the Companys historical losses and the uncertainty of future
taxable income. If the Company begins to generate U.S. taxable income in a
future period or if the facts and circumstances on which its estimates and
assumptions are based were to change, thereby impacting the likelihood of
realizing the deferred tax assets, judgment would have to be applied in
determining the amount of valuation allowance no longer required. Reversal of
all or a part of this valuation allowance could have a significant positive
impact on operating results in the period that it becomes more likely than not
that certain of the Companys deferred tax assets will be realized.
Revenue Recognition
The Company develops, markets, licenses and supports computer software
products and services. For revenue purposes, the Companys products can be
placed into several key revenue categories where each category has similar
revenue recognition traits; Communications Protection subscription based
services, perpetual software license sales, the PocketScript e-prescribing
product, various transaction fees and professional services. Under all
categories, the Company recognizes revenue after all of the following occur:
persuasive evidence of an arrangement exists, delivery has occurred or services
have been rendered, a right of return does not exist, the price is fixed and
determinable, and collectability is reasonably assured. In the event the
arrangement has multiple elements with delivered and undelivered elements, the
delivered elements are recognized only when vendor-specific objective evidence
of fair value (VSOE) exists to allocate the fair value of the total fees to the
undelivered elements of the arrangement.
Communication Protection subscription based services include products such
as ZixMail, ZixVPM, ZixPort, ZixWorks, anti-spam signatures subscription,
anti-virus subscriptions and certain products acquired from MyDocOnline. The
Companys Communications Protection subscription services include delivering
licensed software and providing customer support and secure electronic
communications throughout the subscription period. The customer is often
provided an appliance during the subscription period with pre-installed
software or contractually subscribes to a data center resident service. In a
subscription service, the customer does not own a perpetual right to a software
license, but is instead granted the use of that license during the period of
the subscription. Subscriptions to date have generally been annual
non-refundable contracts. Some of the contracts have automatic renewal
provisions. The subscription period begins on the date specified by the
parties. Revenues from subscription services are recorded as service revenue as
the services are rendered. Subscription fees received from customers in advance
are recorded as deferred revenue and recognized as revenues ratably over the
subscription period.
The Company sells anti-spam filtering, email content filtering, Web
filtering solutions and certain products acquired from MyDocOnline to customers
under perpetual licensing arrangements. These perpetual software licenses are
normally sold as part of multiple element arrangements that include annual
maintenance, and may include implementation or training services. Where VSOE
has not been established for undelivered elements, revenue for all elements is
deferred until those elements have been delivered or their fair values have
been determined. However, if VSOE is determinable for all of the undelivered
elements, and the undelivered elements are not essential to the delivered
elements, the Company will defer recognition of the fair value related to the
undelivered elements and recognize as revenue the remaining portion of the
arrangement through application of the residual method. Evidence of VSOE for
implementation and training services associated with the anti-spam, email
content filtering and Web filtering arrangements is based upon standard billing
rates and the estimated level of effort for the individuals expected to perform
the related services. Installation and training revenues are recognized as the
services are rendered. The Company establishes VSOE for maintenance based upon
contract renewal rates. The Company recognizes maintenance revenue over the
term of the maintenance agreement, generally one year.
The Company recognizes revenue on the PocketScript e-prescribing service
as a multiple element arrangement with separate units of accounting. VSOE is
determined for the undelivered elements and the residual value is assigned to
the device and is recognized upon installation of the device and service at an end-user
location. Installation is determined by physical delivery of a functioning
product. The fair values of the undelivered elements relate to ongoing
services and are recognized ratably over the period of the service. The
Company establishes VSOE for the service elements based upon contract renewal
rates or fair market values if the element is commonly sold by others.
Some of the Companys services incorporate a transaction fee per event
occurrence or when predetermined usage levels have been reached. These fees are
recognized as revenue when the transaction occurs. The Company contracts with
customers to provide certain professional services as stand alone offerings. The
Company recognizes these as revenue as the services are rendered and utilizes
the percentage of completion method when appropriate.
Business Acquisitions
During
2003 and the six months ended June 30, 2004, the Company
completed three acquisitions using the purchase method of accounting. The
amounts assigned to the identifiable assets and liabilities acquired in
connection with these acquisitions were based on estimated fair values as of
the date of the acquisition, with the remainder recorded as goodwill. The fair
values were determined by management, generally based upon information supplied
by the management of the acquired entities and in two instances valuations
prepared by independent appraisal experts. The fair values have been based
primarily upon future cash flow projections for the acquired assets, discounted
to present value using a risk-adjusted discount rate. In connection with these
acquisitions, we have recorded a significant amount of intangible assets and
goodwill.
Results of Operations
Revenues
The following table sets forth, for the periods indicated, a year-over
comparison of the key components of the Companys revenues:
The increase in revenues in the three months-ended June 30, 2004 compared
to the corresponding period in 2003 reflects an increase of approximately
$1,126,000 of secure e-messaging subscription fees generated from new U.S.
corporate customers primarily in the healthcare sector, $442,000 in email
content and Web filtering software sales as well as $645,000 in related
maintenance in relation to the Elron Software acquisition, $375,000 in relation
to the acquisition of PocketScript for electronic prescription services and
$153,000 in relation to the acquisition of MyDocOnline for Internet-based
healthcare services partially offset by $234,000 of services revenue in 2003
related to the Entrust Marketing Agreement described below.
15
Secure e-messaging products are subscription based products, the Elron
acquired products are primarily sold as perpetual licenses, the PocketScripts
acquired products are sold as an e-prescribing service and the MyDocOnline
acquired products fall into either a subscription based arrangement or a
perpetual license sale. All or part of these products might incorporate a
transaction fee element where a per event occurrence can generate service
revenue. Additionally, the Company offers certain professional services as
stand alone offerings or in conjunction with our products. The Company
recognizes these as revenue as the services are rendered and utilizes the
percentage of completion method when appropriate.
The increase in revenues in the six months-ended June 30,2004 compared to
the corresponding period in 2003 reflects an increase of approximately
$2,397,000 of secure e-messaging subscription fees generated from new U.S.
corporate customers primarily in the healthcare sector, $769,000 in email
content and Web filtering software sales, as well as, $1,221,000 in related
maintenance in relation to the Elron Software acquisition, $516,000 in relation
to the acquistion of PocketScript for electronic prescription services and
$276,000 in relation to the acquisition of MyDocOnline for Internet-based
healthcare services partially offset by $468,000 of services revenue related to
the Entrust Marketing Agreement described below.
Service revenues in 2003 included quarterly revenues of $234,000 resulting
from the pro-rata recognition of certain minimum payments associated with the
Marketing Agreement with Entrust. These minimum payments aggregating $3,750,000
were being recognized as revenue ratably over the four year maximum service
period ending in December 2005. Entrust paid the Company a $1,000,000
guaranteed minimum payment in January 2003. In July 2003, the Company and
Entrust mutually agreed to terminate the marketing agreement, because the
marketing agreement, as structured, no longer served their respective business
interests. In connection with the termination of the marketing agreement,
Entrust paid the Company $700,000 and the scheduled minimum guaranteed payments
to have been made in 2004 and 2005, totaling $2,750,000, were cancelled.
A Master Services Agreement was entered into with Aventis for $4,000,000
on the same date as the MyDocOnline acquisition for the performance, by the Company, of
various future services. The services are to be delivered in minimum amounts
of $1,000,000, $1,000,000 and $2,000,000 prior to the first, second and third
calendar year anniversary dates of the acquisition closing, respectively. The
services will be defined on an ongoing basis over the life of the agreement and
valued in accordance with similar pricing for similar services rendered to
other customers. Aventis paid the $4,000,000 upon execution of the
Master Services Agreement.
16
Aventis paid the $4,000,000 upon execution of the Master Services
Agreement.
The Companys services, to be provided to Aventis, have not yet been fully
defined; therefore, the liability has been recorded as a customer
deposit. As the services are defined and priced in individual project
agreements, the value of the defined element will be reclassified to deferred
revenues and then recognized as revenue in accordance with applicable revenue
recognition criteria. Aventis will forfeit any unused amounts annually if
services are not requested by Aventis in accordance with the terms of the
Master Services Agreement. The Company is
required to return to Aventis any unused portion of the deposit only in the
event of material breach of the contract by the Company, in the event the
Company or a party employed or engaged by the Company is debarred pursuant to
the Generic Drug Enforcement Act of 1992 or similar state, local or foreign
law, in the event ZixCorp files for bankruptcy, or in the event of force
majeure. The Company believes that it is unlikely any of these events will
occur. The Companys obligations associated with the Master Services Agreement
are secured by a first priority lien on the Companys property and equipment
and accounts receivable. As of June 30, 2004, the Company has
provided $40,000 of services to Aventis under this Master Services
Agreement.
The Companys end-user order backlog as of June 30, 2004, increased to
approximately $23,678,000, and is comprised of the following elements:
$3,960,000 from the original $4,000,000 customer deposit from Aventis for
future services, $6,418,000 of deferred revenue that has been billed and paid,
$1,950,000 billed but unpaid and approximately $11,350,000 of unbilled
contracts. Approximately 55% to 65% of the backlog is expected to be recognized
as revenue in the next twelve months. The timing of revenue is affected by the
length of time required to deploy a service and the length of the service. The
backlog is a mix of contracts of varying lengths of service. The Companys
end-user order backlog is comprised of contractually bound agreements that the
Company expects to fully amortize into revenue with one possible exception. In
the backlog is $2,500,000 from a customer for the PocketScripts e-prescribing
services. This amount, which is part of a follow-on order to a previous order
for the PocketScript e-prescribing services, is subject to successful
deployment and usage provisions of the services requested in the previous
order.
Management
follows several general metrics to gauge business performance
and the results of these metrics can have an affect on managements estimate of
future revenue. These metrics include: order input, renewal rate (customer
retention) of service contracts, mix of single or multi-year service contracts
and deployment statistics for the Companys products and services. In
particular, as the market for e-prescription solutions matures, the number of
our e-prescribing devices deployed to physicians and the prescription volume
written by such physicians will become increasingly important metrics.
Cost of revenues
The following table sets forth, for the periods indicated, a
year-over-year comparison of the Companys cost of revenues:
The increase in cost of revenues in the three months ended June 30, 2004
compared to the corresponding period in 2003 reflects an increase in cash
expenses of $1,537,000 and non-cash expenses of $313,000. The increase
17
in cash expenses is primarily due to $995,000 of incremental operating
costs, consisting of approximately $69,000 for personnel and $926,000 for
non-personnel operating costs resulting from the recent acquisitions of
PocketScript, Elron Software and MyDocOnline and $542,000 due primarily to
personnel additions totaling $360,000 and non-personnel cost increases totaling
$182,000 which were necessary to expand the Companys deployment and client
services capabilities to support the order growth of the Companys secure
messaging products and services. Non-personnel costs primarily include expenses
for data center maintenance and support and occupancy costs. The increase in
non-cash expenses is primarily due to $498,000 of incremental operating costs
associated with the recent acquisitions of PocketScript, Elron Software and
MyDocOnline, primarily consisting of $323,000 for the amortization of
intangible assets and $175,000 for the depreciation and amortization of
property and equipment, partially offset by a reduction in depreciation and
amortization of property and equipment for secure messaging and resulting from
certain data center equipment becoming fully depreciated.
The increase in cost of revenues in the six months ended June 30, 2004
compared to the corresponding period in 2003 reflects an increase in cash
expenses of $2,728,000 and non-cash expenses of $536,000. The increase in cash
expenses is primarily due to $1,629,000 of incremental operating costs,
consisting of approximately $168,000 for personnel and $1,461,000 for
non-personnel operating costs resulting from the recent acquisitions of
PocketScript, Elron Software and MyDocOnline and $1,099,000 due primarily to
personnel additions totaling $720,000 and non-personnel cost increases totaling
$379,000 which were necessary to expand the Companys deployment and client
services capabilities to support the order growth of the Companys secure
messaging products and services. Non-personnel costs primarily include expenses
for data center maintenance and support and occupancy costs. The increase in
non-cash expenses is primarily due to $952,000 of incremental operating costs
associated with the recent acquisitions of PocketScript, Elron Software and
MyDocOnline, primarily consisting of $601,000 for the amortization of
intangible assets and $342,000 for the depreciation and amortization of
property and equipment, partially offset by a reduction in depreciation and
amortization of property and equipment for secure messaging and resulting from
certain data center equipment becoming fully depreciated.
A significant portion of the Companys cost of revenues has not been and
is not expected to be directly variable to the revenue generated, such as the
cost of operating and maintaining the ZixSecure Center which is currently not
fully utilized. Accordingly, costs associated with the data center are expected
to grow at a much slower pace than revenue. Cost of revenues also includes the
activities of field deployment, professional services and customer service and
support. For the Communication Protection products and services, in the near
term, the Company expects to grow the cost of revenues for these products and
services at rates less than the associated revenue growth rates for the same
products. For the Care Delivery products and services, in the near term, the
Company expects cost of revenues for these products to increase at rates equal
to or greater than the associated revenue growth rates for the same products.
Additionally, other than the non-cash amortization of the fair value of
developed technology acquired with the purchase of Elron Software, cost of
revenues related directly to software sales has not been significant.
Research and development expenses
The following table sets forth, for the periods indicated, a
year-over-year comparison of the Companys research and development expenses:
The increase in research and development expenses in the three months
ended June 30, 2004 compared to the corresponding period in 2003 reflects
primarily an increase in cash expenses. This increase is due primarily to
$1,185,000 of incremental operating costs, consisting of $682,000 for personnel
and $494,000 for non-personnel operating costs, resulting from the recent
acquisitions of PocketScript, Elron Software and MyDocOnline. Non-personnel
operating costs primarily include expenses for outside consultants, occupancy
costs and travel.
18
The increase in research and development expenses in the six months ended June
30, 2004 compared to the corresponding period in 2003 reflects an increase of
$2,345,000 in cash expenses and $388,000 in non-cash expenses. The increase
in cash expenses is due primarily to $2,366,000 of incremental operating costs,
consisting of $1,500,000 for personnel and $866,000 for non-personnel operating
costs, resulting from the recent acquisitions of PocketScript, Elron Software
and MyDocOnline. Non-personnel operating costs primarily include expenses for
outside consultants, occupancy costs and travel. The increase in non-cash
expenses consisted primarily of $306,000 for the in-process research and
development expense associated with the acquisition of MyDocOnline and recorded
in the first quarter of 2004, $162,000 for common stock issued in lieu of cash
compensation for employee bonuses and severance costs and slight decreases in
depreciation and amortization of property and equipment resulting from certain
equipment becoming fully depreciated.
Selling, general and administrative expenses
The following table sets forth, for the periods indicated, a
year-over-year comparison of the Companys selling, general and administrative
expenses:
The increase in selling, general and administrative expenses in the three
months ended June 30, 2004 compared to the corresponding period in 2003
reflects an increase of $1,760,000 in cash expenses and a $1,057,000 increase
in non-cash expenses. The increase in cash expenses is primarily due to the
incremental operating costs resulting from the recent acquisitions of
PocketScript, Elron Software and MyDocOnline totaling $2,501,000 which consists
of $1,666,000 for personnel costs and $835,000 for non-personnel costs.
Operating expenses, excluding personnel costs, for the recent acquisitions
consisted principally of travel, facility costs, advertising and promotion and
third-party consulting totaling $230,000, $240,000, $84,000 and $173,000,
respectively. These incremental operating expenses were partially offset by
reductions in operating expenses for secure messaging products and services and
consist principally of advertising and promotion, third party consulting and
business insurance totaling $302,000, $235,000 and $213,000, respectively.
Also related to the secure messaging products and services, personnel costs
remained relatively flat between periods although approximately $424,000 of
severance costs originally accrued as an anticipated cash expenditure was
subsequently satisfied with non-cash payments. This decrease in cash expense
for the comparable periods was offset by increases primarily in accrued
vacation expense and management bonuses, employee benefits and professional
services for employee recruitment totaling $236,000, $99,000 and $91,000,
respectively.
The increase in non-cash expenses in the three months ended June 30, 2004
compared to the corresponding period in 2003 primarily consists of $542,000 for
employee severance costs resulting from the acceleration of the vesting of
certain stock options held by the terminated employees, usually in lieu of cash
payments per their respective severance agreements; $480,000 due to employee
sales commissions paid using Company common stock; $119,000 for amortization of
intangible assets associated with the acquisition of Elron Software; and,
partially offset by a $140,000 decrease in stock-based compensation related to
stock option grants for employees and third party service providers.
The increase in selling, general and administrative expenses in the six
months ended June 30, 2004 compared to the corresponding period in 2003
reflects an increase of $3,676,000 in cash expenses and a $2,424,000 increase
in non-cash expenses. The increase in cash expenses is primarily due to the
incremental operating costs resulting from the recent acquisitions of
PocketScript, Elron Software and MyDocOnline totaling $4,625,000, which
consists of $2,867,000 for personnel costs and $1,758,000 for non-personnel
costs. Operating expenses, excluding personnel costs, for the recent
acquisitions consisted principally of travel, facility costs, advertising and
promotion and third-
19
party consulting totaling $499,000, $426,000, $261,000 and $310,000,
respectively. These incremental operating expenses were partially offset by
reductions in operating expenses for secure messaging products and services and
consist principally of advertising and promotion, third party consulting and
business insurance totaling $633,000, $407,000 and $427,000, respectively.
These expense decreases relating to the secure messaging products and services
were partially offset by increases in personnel costs consisting of
approximately $502,000 for sales commissions, benefits costs and employee
recruitment costs.
The increase in non-cash expenses in the six months ended June 30, 2004
compared to the corresponding period in 2003 primarily consists of $1,428,000
for employee severance costs resulting from the acceleration of the vesting of
certain stock options held by the terminated employees, usually in lieu of cash
payments per their respective severance agreements; $951,000 due to employee
sales commissions paid using Company common stock; $307,000 for amortization of
intangible assets associated with the acquisitions of Elron Software and
MyDocOnline; and, partially offset by a $295,000 decrease in stock-based
compensation related to stock option grants for employees and third party
service providers.
Investment and other income
Investment income increased from $30,000 and $71,000 for the three months
and six months ended June 30, 2003 to $79,000 and $137,000 for the
corresponding periods in 2004 primarily due to the increase in invested cash
and marketable securities.
Interest expense
The interest expense of $85,000 and $140,000 for the three and six month
periods ended June 30, 2004 represents interest on the promissory note issued
in connection with the acquisition of MyDocOnline in January 2004.
Gain on investments
The realized gains on investment of $70,000 for the six-month period ended
June 30, 2004 and the $530,000 for the three-month and six-month periods ended
June 30, 2003 represents cash payments received from Maptuit Corporation
(Maptuit) as partial recovery of an investment previously written off in
2001. In 2001, the Company recorded an impairment write-off of $5,000,000 for
its related party investment in Maptuit. In October 2002, in connection with
the requirements of a $6,000,000 financing package executed by Maptuit, the
Company exchanged its $5,000,000 debt and equity position in Maptuit for
$154,000 in cash, a non-interest bearing $900,000 subordinated promissory note
due in 2006 and two million shares of common stock of Maptuit. In June 2003,
the Company exchanged the $900,000 subordinated promissory note and one million
shares of common stock of Maptuit for $530,000 in cash and in February 2004,
the Company exchanged the remaining one million shares of stock for $70,000 in
cash.
Income taxes
The Companys income tax expense increased slightly from $24,000 and
$48,000 for the three months and six-months ended June 30, 2003 to $27,000 and
$56,000 for the corresponding periods in 2004. These provisions represent
non-U.S. taxes payable resulting from the operations of the Companys Canadian
subsidiary. The income taxes on the pre-tax loss is different from the U.S.
statutory rate of 34%, primarily due to unbenefitted U.S. losses. The Company
has fully reserved its net deferred tax assets due to the uncertainty of future
taxable income. There may be limitations on the Companys ability to fully use
its substantial net operating loss carryforwards against any future taxable
income, including potential limitations due to ownership changes as defined in
Section 382 of the Internal Revenue Code.
Liquidity and Capital Resources
Net cash used by operations was $9,512,000 for the six months ended June
30, 2004 compared to $8,448,000 for the corresponding period in 2003. The
increase in cash flows used for operating activities totaling $1,064,000 was
primarily due to a 62% increase in the Companys net loss, totaling $7,928,000,
an increase in non-acquired
20
accounts receivable and prepaid expenses totaling $1,465,000, a decrease
in non-acquired deferred revenue totaling $790,000, partially offset by the
$4,000,000 customer deposit from Aventis under the Master Services Agreement, a
$1,306,000 increase in trade payables and accrued expenses, a $3,353,000
increase in the 2004 non-cash operating expenses in the areas of depreciation
and amortization and stock-based compensation and $460,000 related to the
recovery of investment in Maptuit Corporation. Net cash used by operating
activities in 2004 was funded primarily by existing cash resources and
investing and financing activities described below.
Net cash flows provided by investing activities was $48,000 for the six
months ended June 30, 2004 compared to $1,376,000 for the corresponding period
in 2003. The decrease in investing cash flows were primarily attributable
$763,000 of, period over period, increased purchases of property and equipment
as the Company continues to upgrade certain computer hardware in its data
center and acquire computer equipment to satisfy customer orders for the
Companys products and services, primarily ZixVPM and ZixWorks, and a net
reduction of $460,000 in payments received from Maptuit Corporation, period
over period, relating to the Companys previous investment and impairment of
its investment in Maptuit Corporation.
Net cash provided by financing activities was $23,676,000 for the six
months ended June 30, 2004 compared to $7,183,000 for the corresponding period
in 2003. The increase in financing cash flows was attributable to $20,676,000
resulting from the exercise of stock options and warrants by employees and
outside holders during the first half of 2004 to purchase 2,340,215 shares of
the Companys common stock at an average price per share of $8.84 and
$3,000,000 of cash received in connection with the promissory note
to Aventis.
Concurrent with the MyDocOnline acquisition, at closing Aventis, Inc.
(Aventis) loaned the Company $3,000,000 due March 15, 2007, which loan bears
interest at an annual rate of 4.5%. The loan is evidenced by a secured
promissory note. Interest on the note is payable only in services provided by
the Company to Aventis unless there is an event of default. The principal
portion of the note is payable in either cash or shares of the Companys common
stock, based on the then current value of such shares, at the option of the
Company and may be prepaid by the Company at any time without penalty.
Additionally, at Aventis discretion and after the $4,000,000 customer deposit
from Aventis under the Master Services Agreement described below has been
consumed, the principal portion of the note may be paid in the form of
additional services provided to Aventis by the Company pursuant to the terms of
such services agreement. Should Aventis choose to not have the note paid in the
form of services, the Company is required to pay the note in cash or stock at
maturity, however, at an amount equal to 90% of the face amount of the loan, or
$2,700,000, which the Company considers its minimum liability.
Concurrent with the
issuance of the note payable to Aventis, the Company issued
warrants to purchase 145,853 shares of ZixCorp commons stock. The exercise
price and term of the warrants is $13.01 per share and three years, respectively.
Based on relative fair values at time of issuance, the loan proceeds were
allocated to the note payable of $1,525,000 and to the warrants of $1,475,000.
The fair value of the warrants was calculated using the Black-Scholes pricing
model. The fair value of the note was calculated based on an estimated
interest rate that the Company could obtain independently. The resulting
discount of $1,175,000 on the minimum liability of $2,700,000 represents
unamortized debt discount which is being amortized to interest expense over the
three year loan life to yield an effective interest rate of 11%. This rate
approximates a cost of borrowing valuation estimated by an
independent valuation company. The loan is secured by the
Companys property and equipment and accounts receivable pursuant to a security
agreement.
At June 30, 2004, the Companys principal source of liquidity was its net
working capital position of $16,926,000, including cash and marketable
securities of $26,177,000. The Company plans to continue to invest its excess
cash primarily in short-term, high-grade commercial paper, U.S. government and
agency securities or money market funds. The Companys cash requirements
consist principally of funding the Companys operating losses as it pursues a
leadership position in the emerging markets in which it operates and capital
expenditures, primarily for data center expansion and refurbishment and for
computer equipment to support new customer orders. The Company anticipates
further losses in 2004 and the use of cash resources for operating activities
continues at a substantial level. To complement and expand our business and
product offerings, the Company acquired the assets and the businesses of
PocketScript, Elron Software and MyDocOnline in July 2003, September 2003 and
January 2004, respectively, in exchange for certain equity securities of the
Company. While no significant cash was required to make these acquisitions,
each of these businesses have incurred operating losses in recent years. The
Company expects to significantly and quickly reduce the substantial historical
operating losses of MyDocOnline based upon a reduced number of employees and
contractors, strategic expense cuts, expected increases in sales volumes and
anticipated cost synergies with its existing businesses. The Company expects
to incur operating losses in the near term from the operation of its
PocketScript operations as it continues to invest in new personnel and other
resources necessary to effectively deploy its e-prescription devices.
21
The amount of the Companys future cash requirements depends primarily on
the market acceptance of its products and services and the timing and magnitude
of cash flows generated from new customer orders. Cash flows will also be
impacted by capital expenditure requirements, resources devoted to the
additional development of our products and services and resources devoted to
sales and marketing including discretionary advertising initiatives. The
Company expects the market for its products and services to expand as the
business community recognizes the importance of privacy and security for
electronic communications and as electronic prescription initiatives mature in
the marketplace. The Company may need to raise additional funds in the future
to sustain its operations or initiate reductions in operating expenses, or
both. The Company will continue to consider various capital funding
alternatives to strengthen its financial position. These capital funding
alternatives could involve one or more types of equity securities, including
convertible debt, common or convertible preferred stock and warrants to acquire
common or preferred stock. Such equity securities could be issued at or below
the then-prevailing market price for shares of the Companys common stock. The
Company currently has no existing credit facilities. There can be no assurances
that the Company will be able to raise additional capital on satisfactory terms
if and when needed.
Options and Warrants of ZixCorp Common Stock
In 2003 and into 2004, the Company raised significant cash from
individuals who hold warrants and options in the Companys common stock as they
exercised these warrants and options. The Company continues to have significant
warrants and options outstanding that are currently vested. The extent of
future cash inflow from additional warrant and option activity is not certain
and is likely to be less than the Company experienced in the prior three
quarters. The following table summarizes the warrants and options that are
outstanding as of June 30, 2004. The vested shares are a subset of the
outstanding shares. The value of the shares is the number of shares multiplied
by the exercise price for each share.
Off-Balance Sheet Arrangements, Contractual Obligations, and Contingent Liabilities and Commitments
The following table aggregates the Companys material contractual cash
obligations as of June 30, 2004:
The Company also has severance agreements with certain employees that
would require the Company to pay approximately $2,970,000 if all such employees
separated from employment with the Company following a change of control, as
defined in the severance agreements.
22
Risks and Uncertainties
We continue to use significant amounts of cash.
Since 1999, we have been developing and marketing products and services
that bring privacy, security and convenience to Internet users, with a
particular focus in the healthcare sector. Our businesses operate in emerging
markets, and developing these businesses is costly and the market is highly
competitive. Emerging market businesses involve risks and uncertainties, and
there are no assurances that we will be successful in our efforts. We have
experienced significant operating losses in recent years and utilization of
cash resources continues at a substantial level. ZixCorp anticipates further
losses in 2004.
Our recent acquisitions of three companies may require us to invest
significant resources to make them successful.
In July 2003, we acquired substantially all of the assets of PocketScript,
LLC, a provider of electronic prescription solutions for the healthcare
industry; in September 2003, we acquired substantially all of the assets of
Elron Software Inc., a provider of anti-spam, email content filtering and Web
filtering solutions; and in late January 2004, we acquired substantially all of
the assets of MyDocOnline, a provider of secure Web-based communications and
laboratory information solutions. PocketScript and MyDocOnline are start-up
ventures in emerging markets. While Elron has been in business for a number of
years, its revenues have declined in recent years. PocketScript, Elron, and
MyDocOnline have incurred operating losses in recent years. The ability to
increase the companies revenues in the near future is largely dependent upon,
in Elrons case, whether our efforts to bring enhanced and new products to
market are successful, and in the case of PocketScript and MyDocOnline, whether
we are able to develop the market for their products and services. Our
challenge is to make these new subsidiaries profitable. To do so may require us
to invest significant resources, including significant amounts of cash, and
there are no assurances that these subsidiaries will become profitable in the
near term.
The market may not broadly accept our products and services, which would
prevent us from operating profitably.
We must be able to achieve broad market acceptance for our products and
services in order to operate profitably. We have not yet been able to do this.
To our knowledge, there are currently no secure e-messaging protection and
transaction businesses similar to our Zix branded business that currently
operate at the scale that we would require, at our current expenditure levels
and pricing, to become profitable. As previously noted, PocketScript and
MyDocOnline are start-up ventures in emerging markets. There is no assurance
that our products and services will become generally accepted or that they will
be compatible with any standards that become generally accepted, nor is there
any assurance that enough paying users will ultimately be obtained to enable us
to operate profitably.
Competition in our businesses is expected to increase, which could cause
our business including the business of our recently acquired subsidiaries -
to fail.
Our Zix branded solutions are targeted to the secure e-messaging
protection and transaction services market. Elrons product solutions have
enabled us to enhance our Zix branded protection management services by adding
a
23
new feature set to our anti-virus, anti-spam and email content filtering
services while expanding our offering to include URL filtering. Our
PocketScript and MyDocOnline businesses are targeted toward the emerging
markets for electronic prescriptions and online communication among the
healthcare community. As the publics and governmental authorities awareness
about the need for privacy and security of electronic communications has
increased over the past few years, an increasing number of competitors have
entered the market.
Although there are many large, well-funded participants in the information
technology security industry, few currently participate in the secure
e-messaging protection and transaction services market in which our Zix branded
solutions compete. Most other product-only solutions in this market require
extensive increases in overhead to implement and deploy them. Our Zix branded
solutions can be made operational in a very short period of time compared to
the longer procurement and deployment cycles common with the solutions of many
of our competitors. Our service and product offerings are focused on the secure
communications market, including secure e-messaging and protection management.
Companies that compete with our Zix branded secure e-messaging and protection
business include content management and secure delivery companies, such as
Authentica, Inc., Certified Mail, Sigaba Corporation and Tumbleweed
Communications Corp., and other messaging/spam protection participants such as
BrightMail Incorporated, CipherTrust, Inc., ClearSwift Limited, FrontBridge
Technologies, Inc., MessageLabs, Postini, Inc., NetIQ Corp. and SurfControl
Incorporated.
Our Zix branded products and Elron products also compete with several
product companies that deliver anti-virus solutions that may also contain
limited email messaging/spam protection capabilities, including Network
Associates, Inc. (McAfee), Sophos, Inc., Symantec Corporation and Trend Micro,
Inc. We also compete with companies that offer Web filtering products, such as
Secure Computing Corporation, SurfControl Incorporated, Websense, Inc. and
NetIQ Corp.
In addition, we face competition from vendors of Internet server
appliances, operating systems, networking hardware, network management
solutions and security software, many of which now, or may in the future,
develop or bundle secure e-messaging, messaging/spam protection and/or Web
filtering capabilities into their products.
We may face increased competition as these competitors partner with others
or develop new product and service offerings to expand the functionality that
they can offer to their customers. We believe that the secure e-messaging
protection and transaction services market is growing, unlike many segments of
the information technology security industry which are not growing. We have
spent several years on infrastructure development and product development. Our
competitors may, over time, develop new technologies that are perceived as
being more secure, effective or cost efficient than our own. These competitors
could successfully garner a significant share of the market, to the exclusion
of our company. Furthermore, increased competition could result in pricing
pressures, reduced margins or the failure of our business to achieve or
maintain market acceptance, any of which could harm our business.
Our PocketScript electronic prescription management services allow
healthcare payors to effectively deliver drug information to physicians at the
point of care, enabling providers to work more effectively within established
formularies. Our PocketScript services, targeted to the e-prescription
marketplace, are expected to grow as more physicians are leveraging technology
in delivering healthcare services, coupled with the fact that the number of
prescriptions written annually in the United States continues to increase.
Participants in the e-prescribing space include AllScripts Healthcare
Solutions, Ramp Corporation, Dr. First, Inc. and iScribe (a division of
AdvancePCS).
Our recently acquired MyDocOnline business offers a variety of
Internet-based healthcare services. MyDocOnline Connect is a subscription-based
Web service that allows patients and physicians to securely communicate online.
Connect helps patients become more active, informed participants in their own
health. Communication features offered by the service cover the spectrum of
patient needs, and include: online doctor visits, administrative questions,
appointment requests, billing questions, prescription requests, and referral
requests. The service also offers a host of educational, interactive content
features that deliver condition-specific health information to patients.
Connect competitors include Medem, Inc., RelayHealth Corporation and MedFusion,
Inc. with respect to the communication features, and WebMD Corporation with
respect to the content resources. We believe that Connect offers superior
services in the online doctor visit arena with its ability to intelligently evaluate symptoms, control template availability at a granular level,
and enable patients to include their health history; and its compatibility with
the vast
24
number of business/financial arrangements that exist in the healthcare
industry. Nevertheless, we expect to face increasing competition in this arena
and our competitors may develop products and services that are perceived to be
better than ours.
Dr. Chart®, also a Web-based communication tool of ours, connects
healthcare providers and laboratories by allowing doctors to initiate lab
orders, check medical necessity compliance and view results rapidly and
accurately using a secure Internet connection. Dr. Chart also automatically
integrates patient information, customizes requisition formats for individual
practices, automatically prints specimen labels, automatically checks Medicare
compliance and provides an up-front Advanced Beneficiary Notification (ABN) at
point of order and allows labs to enhance reporting with historical analyses,
trending, and graphing. Dr. Chart seamlessly integrates into labs current
systems and is fully customizable. Competitors include: 4Medica, Inc., Cerner
Corporation and Misys plc. All of the competitors offer the same basic services
that Dr. Chart offers, although we believe that Dr. Chart is superior to
services offered by its competitors because of the flexibility of the product,
expertise in interfacing to other systems, and duration and breadth of
experience delivering Internet-based orders and solutions to labs nationwide.
Nevertheless, we expect to face increasing competition in this arena and our
competitors may develop products and services that are perceived to be better
than ours.
Our inability to successfully and timely develop and introduce new
e-messaging protection and transaction products and related services and to
implement technological changes could harm our business.
The emerging nature of the secure e-messaging protection and transaction
services business and its rapid evolution require us continually to develop and
introduce new products and services and to improve the performance, features
and reliability of our existing products and services, particularly in response
to competitive offerings. Our Elron business, while having a significant
customer base and meaningful revenues, has not been profitable in recent years
under its prior ownership.
We also have under development new feature sets for our current Zix
branded product line and service offerings and are considering new secure
e-messaging products and services. By adding Elrons product line to our
current service offerings, we will be able to accelerate the development time
we would have otherwise needed to build additional feature sets into our Zix
branded product and service offerings. The success of new or enhanced products
and services depends on several factors primarily, market acceptance. We may
not succeed in developing and marketing new or enhanced products and services
that respond to competitive and technological developments and changing
customer needs. This could harm our business.
If the market for secure e-messaging protection and transaction services
does not continue to grow, demand for our products and services will be
adversely affected.
The market for secure electronic communications is a developing market.
Continued growth of the secure e-messaging protection and transaction services
market will depend to a large extent on the market recognizing the need for
secure electronic communications, such as email encryption and e-prescribing.
Failure of this market to grow would harm our business.
If healthcare providers fail to adopt the PocketScript and MyDocOnline
Care Delivery Solutions, we will fail to achieve the critical mass of
physicians and patients to build a successful business.
Our PocketScript electronic prescription management services and our
MyDocOnline services are targeted to the emerging market for providing secure
communications among healthcare providers to deliver information in an
efficient, economical manner. These are emerging markets, and the success of
our PocketScript and MyDocOnline services is dependent, in large measure, on
physicians and other healthcare providers changing the manner in which they
conduct their medical practices by beginning to use secure wireless and
Internet communications channels to communicate with their patients, medical
laboratories, payors, drug formularies, and others. Our challenge is to make
these new businesses profitable. To do so may require us to invest significant
resources, including significant amounts of cash, and there are no assurances
that these businesses will become profitable in the near term.
Capacity limits on our technology and network hardware and software may be
difficult to project, and we may not be able to expand and upgrade our systems
to meet increased use, which would result in reduced revenues.
While we have ample through-put capacity to handle our customers
requirements for the medium term, at some point we may be required to
materially expand and upgrade our technology and network hardware and software.
We may not be able to accurately project the rate of increase in usage on our
network, particularly since we have significantly expanded our potential
customer base by our recent acquisition of PocketScript and MyDocOnline, whose
service offerings are supported by our ZixSecure CenterTM. . In addition, we
may not be able to expand and upgrade, in a timely manner, our systems and
network hardware and software capabilities to accommodate increased traffic on
our network. If we do not timely and appropriately expand and upgrade our
systems and network hardware and software, we may lose customers and revenues.
Security interruptions to our data centers could disrupt our business, and
any security breaches could expose us to liability and negatively impact
customer demand for our products and services.
Our business depends on the uninterrupted operation of our data centers -
currently, our ZixSecure Center located in Dallas, Texas; the Austin, Texas
data center used for fail-over and and business continuity services; and the
Cincinnati data center used for quality assurance and staging of new customers
of our PocketScript e-prescribing
25
service. We must protect these centers from
loss, damage or interruption caused by fire, power loss, telecommunications
failure or other events beyond our control. Any damage or failure that causes
interruptions in our data centers operations could materially harm our
business, financial condition and results of operations.
In addition, our ability to issue digitally-signed certified time-stamps
and public encryption codes in connection with our Zix branded products and
services and to support PocketScripts e-prescribing services and MyDocOnlines
services depends on the efficient operation of the Internet connections between
customers and our data centers. We depend on Internet service providers
efficiently operating these connections. These providers have experienced
periodic operational problems or outages in the past. Any of these problems or
outages could adversely affect customer satisfaction.
Furthermore, it is critical that our facilities and infrastructure remain
secure and the market perceives them to be secure. Despite our implementation
of network security measures, our infrastructure may be vulnerable to physical
break-ins, computer viruses, attacks by hackers and similar disruptions from
unauthorized tampering with our computer systems. In addition, we are
vulnerable to coordinated attempts to overload our systems with data, resulting
in denial or reduction of service to some or all of our users for a period of
time. We do not carry insurance to compensate us for losses that may occur as a
result of any of these events; therefore, it is possible that we may have to
use additional resources to address these problems.
Secure messages sent through our ZixPort® and ZixMessage CenterTM
messaging portals in connection with the operation of our secure e-messaging
protection and transaction services, will reside, for a user-specified period
of time, in our secure data center network; individual prescription histories
transmitted through our PocketScript system will reside in our secure data
center network; and the personal healthcare information transmitted through our
MyDocOnline system will reside in our secure data center network. Any physical
or electronic break-ins or other security breaches or compromises of this
information could expose us to significant liability, and customers could be
reluctant to use our Internet-related products and services.
We may have to defend our rights in intellectual property that we use in
our products and services, which could be disruptive and expensive to our
business.
We may have to defend our intellectual property rights or defend against
claims that we are infringing the rights of others. Intellectual property
litigation and controversies are disruptive and expensive. Infringement claims
could require us to develop non-infringing products or enter into royalty or
licensing arrangements. Royalty or licensing arrangements, if required, may not
be obtainable on terms acceptable to us. Our business could be significantly
harmed if we are not able to develop or license the necessary technology.
Furthermore, it is possible that others may independently develop substantially
equivalent intellectual property, thus enabling them to effectively compete
against us.
Defects or errors could affect the performance of our products and
services.
We subject our Zix branded products and services to quality assurance
testing prior to product release. There is no assurance that the quality and
assurance testing previously conducted by the businesses we acquired on their
current products and services conform to our standards for quality assurance
testing. Regardless of the level of quality assurance testing, any of our
products and services could contain undetected defects or errors. This could
result in loss of or delay in revenues, failure to achieve market acceptance,
diversion of development resources, injury to our reputation, litigation
claims, increased insurance costs or increased service and warranty costs. Any
of these could prevent us from implementing our business model and achieving
the revenues we need to operate profitably.
Public key cryptography technology is subject to risks.
Our Zix branded products and services, the PocketScript e-prescription
service and the MyDocOnline businesses employ, and future products and services
may employ, public key cryptography technology. With public
key cryptography technology, a public key and a private key are used to
encrypt and decrypt messages. The security afforded by this technology depends,
in large measure, on the integrity of the private key, which is dependent, in
part, on the application of certain mathematical principles. The integrity of
the private key is predicated on the
26
assumption that it is difficult to
mathematically derive the private key from the related public key. Should
methods be developed that make it easier to derive the private key, the
security of encryption products using public key cryptography technology would
be reduced or eliminated and such products could become unmarketable. This
could require us to make significant changes to our products, which could
damage our reputation and otherwise hurt our business. Moreover, there have
been public reports of the successful decryption of certain encrypted messages.
This, or related, publicity could adversely affect public perception of the
security afforded by public key cryptography technology, which could harm our
business.
We depend on key personnel.
We depend on the performance of our senior management team including our
chairman and chief executive officer, John A. Ryan, our president and chief
operating officer, Richard D. Spurr and their direct reports and other key
employees, particularly highly skilled technical personnel. Our success depends
on our ability to attract, retain and motivate these individuals. There are no
binding agreements with any of our employees that prevent them from leaving our
company at any time. There is competition for these personnel. In addition, we
do not maintain key person life insurance on any of our personnel. The loss of
the services of any of our key employees or our failure to attract, retain and
motivate key employees could harm our business.
We could be affected by government regulation.
Exports of software products using encryption technology, such as our Zix
branded products and services, are generally restricted by the U.S. government.
Although we have obtained U.S. government approval to export our products to
almost all countries in the world, the list of countries to which our products
cannot be exported could be revised in the future. Furthermore, some foreign
countries impose restrictions on the use of encryption products, such as our
products. Failure to obtain the required governmental approvals would preclude
the sale or use of our products in international markets.
Furthermore, boards of pharmacy in the various states in which our
PocketScript and MyDocOnline businesses operate regulate the process by which
physicians write prescriptions. While regulations in the states in which these
businesses currently generally operate permit the electronic writing of
prescriptions, such regulations could be revised in the future. Moreover,
regulations in states in which these businesses do not currently operate may
not be as favorable and may impede our ability to develop business in these
states. Furthermore, future state or federal regulation could mandate standards
for the electronic writing of prescriptions or for the secure electronic
transmittal of personal health information through the Internet that our
technology and systems do not comply with, which would require us to modify our
technology and systems.
Our stock price may be volatile.
The market price of our common stock has fluctuated significantly in the
past and is likely to fluctuate in the future. Our stock price may decrease as
a result of the dilutive effect caused by the additional number of shares that
may become available in the market due to the issuances of our common stock in
connection with the capital funding and acquisition transactions we completed
over the last year. As of July 15, 2004, there was a short position in our
common stock of 8,506,011.
Our directors and executive officers own a substantial percentage of our
securities. Their ownership could allow them to exercise significant control
over corporate decisions and to implement corporate acts that are not in the
best interests of our shareholders as a group.
Our directors and executive officers beneficially own shares of our
securities that represent approximately 16.2% of the combined voting power
eligible to vote on matters brought before our shareholders, including
securities and associated warrants beneficially owned by Antonio R. Sanchez,
Jr., a former director and father of a current director (Antonio R. Sanchez
III), and current beneficial owner of approximately 7.9% of our outstanding
common stock, and John A. Ryan, our chairman and chief executive officer.
Therefore, our directors and executive officers, if they acted together, could
exert substantial influence over matters requiring approval by our
shareholders.
27
These matters would include the election of directors. This
concentration of ownership and voting power may discourage or prevent someone
from acquiring our business.
Mr. Haywood owns a large percentage of our outstanding stock and could
significantly influence the outcome of actions.
George W. Haywood and an IRA for the benefit of Mr. Haywood beneficially
own approximately 15.4% of our outstanding common stock. Therefore, the
selling shareholder could exert substantial influence over all matters
requiring approval by our shareholders, including the election of directors.
The selling shareholders interests may not be aligned with the interests of
our other shareholders. This concentration of ownership and voting power may
discourage or prevent someone from acquiring our business.
Further issuances of equity securities may be dilutive to current
shareholders.
At some point in the future we may determine to seek additional capital
funding or to acquire additional businesses. These events could involve the
issuance of one or more types of equity securities, including convertible debt,
common or convertible preferred stock and warrants to acquire common or
preferred stock. Such equity securities could be issued at or below the
then-prevailing market price for our common stock. In addition, we incentivize
employees and attract new employees by issuing shares of our common stock and
options to purchase shares of our common stock. Therefore, the interest of our
existing shareholders could be diluted by future share issuances and stock
option grants to employees and any equity securities issued in capital funding
financings or business acquisitions.
We may have liability for indemnification claims arising from the sale of
our previous businesses in 1998 and 1997.
We disposed of our previous operating businesses in 1998 and 1997. In
selling those businesses, we agreed to provide customary indemnification to the
purchasers of those businesses for breaches of representations and warranties,
covenants and other specified matters. Although we believe that we have
adequately provided for future costs associated with these indemnification
obligations, indemnifiable claims could exceed our estimates.
We may encounter other unanticipated risks and uncertainties in the
markets we serve or in developing new products and services, and we cannot
assure you that we will be successful in responding to any unanticipated risks
or uncertainties.
There are no assurances that we will be successful or that we will not
encounter other, and even unanticipated, risks. We discuss other operating,
financial or legal risks or uncertainties in our periodic filings with the
Securities and Exchange Commission (the SEC). We are, of course, also subject
to general economic risks.
NOTE ON FORWARD-LOOKING STATEMENTS AND RISK FACTORS
This document contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 (the Act) and Section 21E of the
Securities Exchange Act of 1934 (the Exchange Act). All statements other than
statements of historical fact are forward-looking statements for purposes of
federal and state securities laws, including: any projections of future
business, market share, earnings, revenues or other financial items; any
statements of the plans, strategies and objectives of management for future
operations; any statements concerning proposed new products, services or
developments; any statements regarding future economic conditions or
performance; any statements of belief; and any statements of assumptions
underlying any of the foregoing. Forward-looking statements may include the
words may, will, predict, plan, should, goal, estimate, intend,
continue, believe, expect, anticipate and other similar words. Such
forward-looking statements may be contained in the RISK FACTORS section
above, among other places.
Although we believe that the expectations reflected in any of our
forward-looking statements are reasonable, actual results could differ
materially from those projected or assumed in any of our forward-looking
statements. Our future financial condition and results of operations, as
well as any forward-looking statements, are
28
subject to change and to inherent
risks and uncertainties, such as those disclosed in this document. We do not
intend, and undertake no obligation, to update any forward-looking statement.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For the six-month period ended June 30, 2004, the Company did not
experience any material changes in market risk exposures with respect to its
cash investments and marketable securities that affect the quantitative and
qualitative disclosures presented in the Companys 2003 Annual Report to
Shareholders on Form 10-K.
ITEM 4. CONTROLS AND PROCEDURES
An evaluation was carried out under the supervision and with the
participation of the Companys management, including its Chief Executive
Officer and Chief Financial Officer, of the effectiveness of the design and
operation of the Companys disclosure controls and procedures (as defined in
Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of
June 30, 2004. Based upon that evaluation, the Chief Executive Officer and
Chief Financial Officer concluded that the design and operation of these
disclosure controls and procedures were effective. There have been no
significant changes in the Companys internal controls or in other factors that
could significantly affect these controls subsequent to the date of their
evaluation.
29
(In thousands, except share data)
June 30, 2004
December 31, 2003
$
20,811
$
6,599
5,366
7,253
736
359
1,153
1,147
28,066
15,358
5,239
3,151
5,409
3,589
9,119
4,321
$
47,833
$
26,419
$
4,900
$
3,738
5,280
4,066
960
11,140
7,804
1,138
696
3,000
1,665
342
312
264,309
230,554
(11,507
)
(11,507
)
(222,254
)
(201,440
)
30,890
17,919
$
47,833
$
26,419
Table of Contents
(In thousands, except per share data)
Three Months
Six Months
Ended June 30
Ended June 30
2004
2003
2004
2003
$
3,079
$
1,014
$
5,595
$
1,653
442
769
3,521
1,014
6,364
1,653
(3,704
)
(1,854
)
(6,878
)
(3,614
)
(2,311
)
(1,219
)
(5,156
)
(2,423
)
(7,349
)
(4,532
)
(15,155
)
(9,055
)
79
30
137
71
(85
)
(140
)
530
70
530
(9,849
)
(6,031
)
(20,758
)
(12,838
)
(27
)
(24
)
(56
)
(48
)
$
(9,876
)
$
(6,055
)
$
(20,814
)
$
(12,886
)
$
(0.31
)
$
(0.31
)
$
(0.67
)
$
(0.66
)
31,688
21,152
30,944
20,862
Table of Contents
(In thousands, except share data)
Common Stock
Additional
Treasury
Accumulated
Total
Stockholders'
Shares
Amount
Capital
Stock
Deficit
Equity
31,155,646
$
312
$
230,554
$
(11,507
)
$
(201,440
)
$
17,919
960,469
9
15,329
15,338
1,379,746
14
5,324
5,338
583,411
6
9,031
9,037
1,475
1,475
166,643
1
1,514
1,515
1,075
1,075
30
30
(23
)
(23
)
(20,814
)
(20,814
)
34,245,915
$
342
$
264,309
$
(11,507
)
$
(222,254
)
$
30,890
Table of Contents
(In thousands)
Six Months
Ended June 30
2004
2003
$
(20,814
)
$
(12,886
)
2,760
1,702
1,075
1,515
30
325
(70
)
(530
)
(29
)
1,436
4,000
2,021
1,505
(9,512
)
(8,448
)
(1,909
)
(1,146
)
(5,077
)
(4,982
)
6,964
6,974
70
530
48
1,376
15,338
5,338
1,575
3,000
5,608
23,676
7,183
14,212
111
6,599
7,586
$
20,811
$
7,697
Table of Contents
(Unaudited)
Table of Contents
June 30, 2004
December 31, 2003
$
2,800,000
$
2,306,000
(114,000
)
(93,000
)
(1,950,000
)
(1,854,000
)
$
736,000
$
359,000
June 30, 2004
December 31, 2003
Weighted
Gross
Gross
Average
Carrying
Net
Carrying
Net
Useful
Amount, at
Accumulated
Carrying
Amount, at
Accumulated
Carrying
Lives
Cost
Amortization
Amount
Cost
Amortization
Amount
3.7 years
$
4,320,000
$
871,000
$
3,449,000
$
2,269,000
$
289,000
$
1,980,000
4 years
1,994,000
346,000
1,648,000
1,336,000
111,000
1,225,000
3 years
432,000
120,000
312,000
432,000
48,000
384,000
$
6,746,000
$
1,337,000
$
5,409,000
$
4,037,000
$
448,000
$
3,589,000
$
941,000
1,885,000
1,547,000
701,000
310,000
25,000
$
5,409,000
Table of Contents
$
9,037,000
282,000
$
9,319,000
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Table of Contents
Three months ended
Variance
Six months ended
Variance
June 30,
2004 vs. 2003
June 30,
2004 vs. 2003
($ in thousands )
2004
2003
$
%
2004
2003
$
%
$
3,079
$
1,014
$
2,065
204
%
$
5,595
$
1,653
$
3,942
238
%
442
442
N/A
769
769
N/A
$
3,521
$
1,014
$
2,507
247
%
$
6,364
$
1,653
$
4,711
285
%
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Payments Due by Period
Remainder of
Contractual Obligations
2004
2005
2006
2007
2008
Thereafter
$
684,000
$
1,110,000
$
925,000
$
903,000
$
905,000
$
1,333,000
2,700,000
207,000
68,000
67,000
$
1,287,000
$
1,178,000
$
992,000
$
3,603,000
$
905,000
$
1,333,000
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
PART II OTHER INFORMATION
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Company held its annual meeting of shareholders on May 6, 2004. At
this meeting, the shareholders elected as directors of the Company, Michael E.
Keane, James S. Marston, John A. Ryan, Antonio R. Sanchez III and Dr. Ben G.
Streetman. The tabulation of votes with respect to the election of directors
is as follows:
The shareholders voted to approve the adoption of the Zix Corporation 2004
Stock Option Plan. The tabulation of votes with respect to the adoption of the
2004 Stock Option Plan is as follows:
The shareholders voted to approve the adoption of the Zix Corporation 2004
Directors Stock Option Plan. The tabulation of votes with respect to the
adoption of the 2004 Directors Stock Option Plan is as follows:
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
a. Exhibits
The following is a list of exhibits filed as part of this Quarterly
Report on Form 10-Q:
30
b. Reports on Form 8-K
The Company filed the following reports on Form 8-K during the three
months ended June 30, 2004:
The Company filed a report on Form 8-K on August 6, 2004
reporting the Companys financial results for the quarter ended
June 30, 2004, and announced as part of that report, its intention to file an Amended Form 10-Q for quarter ending March 31, 2004.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
31
Nominee
Shares For
Shares Withheld
29,263,106
360,877
29,258,881
365,102
29,291,685
332,298
29,279,124
344,859
29,264,106
359,877
14,846,226
1,597,290
117,065
13,063,402
14,728,446
1,649,547
182,588
13,063,402
Description of Exhibits
Amended and Restated Employment Agreement,
effective as of June 1, 2004, between Zix
Corporation and Daniel S. Nutkis.
Stock Option Agreement, dated June 1, 2004,
between Zix Corporation and Daniel S. Nutkis.
Form of Outside Director Stock Option Agreement,
dated January 2, 2004,
Table of Contents
Description of Exhibits
between Zix Corporation and
James S. Marston, Dr. Ben G. Streetman and Michael
E. Keane.
Outside Director Stock Option Agreement, dated May
6, 2004, between Zix Corporation and Antonio R.
Sanchez III.
Services Amendment, effective as of May 10, 2004,
between Zix Corporation and HQ Global Workplaces,
Inc. for lease of office space in Gold River,
California.
Certification of Chief Executive Officer pursuant
to Rule 13a-14(a) under the Securities Exchange
Act of 1934, as amended.
Certification of Chief Financial Officer pursuant
to Rule 13a-14(a) under the Securities Exchange
Act of 1934, as amended.
Certification of John A. Ryan, Chief Executive
Officer, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
Certification of Bradley C. Almond, Chief
Financial Officer, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
+
Management contract or compensatory plan or arrangement.
*
Filed herewith.
**
Furnished herewith.
1.
The Company filed a report on Form 8-K on April 7, 2004
relating to new executive appointments (amended via Form 8-K/A
filed May 6, 2004).
2.
The Company filed a report on Form 8-K/A on April 14, 2004
reporting the historical financial statements of MyDocOnline, Inc.
and certain pro forma financial information (amending Form 8-K
filed February 11, 2004).
3.
The Company filed a report on Form 8-K on May 5, 2004 to
file a press release announcing its financial results for the
quarter ended March 31, 2004, which information was furnished and
not filed with the SEC.
4.
The Company filed a report on Form 8-K on June 23, 2004
announcing a change in its auditors.
ZIX CORPORATION
(Registrant)
By:
/s/ Bradley C. Almond
Bradley C. Almond
Vice President, Chief Financial Officer, and Treasurer
(Principal Financial Officer and
Duly Authorized Officer)
Exhibit 10.1 Execution Version
THIS AGREEMENT CONTAINS AN ARBITRATION PROVISION
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Agreement") is made and entered into effective as of June 1, 2004, by and between Zix Corporation, a Texas corporation (the "Company"), and Daniel S. Nutkis ("Employee"), and amends and restates that certain Employment Agreement, dated December 1, 2003.
RECITALS
A. The Company desires to provide for the continuing employment by Employee with the Company.
B. Employee is willing to continue to serve the Company on the terms and conditions provided in this Agreement.
C. The Company and the Employee are parties to that certain Severance Agreement, dated as of July 1, 2003, between the Company and the Employee (the "Severance Agreement"), which is intended to be cancelled following the execution of this Agreement.
THEREFORE, in consideration of the covenants and agreements contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement agree as follows:
1. Employment. The Company shall employ Employee, and Employee accepts such employment, on the terms and conditions set forth in this Agreement.
2. Term. Subject to Section 8 and the other terms and conditions in this Agreement, the employment of Employee by the Company as provided in Section 1 will be as follows: Employee's employment with the Company shall be on a "full time" basis for the period beginning June 1, 2004, and ending the later of (i) November 30, 2004, or (ii) such later date as the parties may mutually agree. This period of employment is referred to as the period of "full time" employment. Following this period of full time employment, Employee shall be a part time employee of the Company for a period of an additional six months. This period of employment is referred to as the period of "retainer employment." Following the period of retainer employment, the Employee shall be a consultant to the Company for an additional two months. This period is referred to as the "consulting period." Following the execution of this Agreement, Company shall no longer consider Employee to be a "16-b" officer of the Company, although the Employee is to be mindful of the continued applicability of certain provisions of Section 16(b) of the Securities Exchange Act of 1934 and applicable securities laws relating to insider trading.
AMENDED AND RESTATED
EMPLOYMENT AGREEMENT - Page 1
3. Position and Duties. During the "full time" employment period of this Agreement, Employee shall serve as Executive Vice President Strategy of the Company and shall report to the Company's Chief Executive Officer. The duties of the Employee during the full time employment period shall be to (i) evaluate the overall marketplace and advise the Company's Chief Executive Officer on appropriate strategic direction for the Company; (ii) evaluate the Company's key strategic relationships and advise as to recommended courses of action with respect to these relationships; (iii) advise as to recommended courses of action with respect to potential acquisition or business combination candidates; (iv) provide leadership in the area of regulation and standards; (v) assist the Company's Chief Medical Officer in establishing the Company's Medical Advisory Board; and (vi) perform such other tasks as may be reasonably assigned by the Company's Chief Executive Officer. During the retainer employment period, Employee shall perform such tasks as may be reasonably assigned by the Company's Chief Executive Officer for up to 4 days per calendar month and additional work as mutually agreed. During the "full time" and "retainer employment" periods, Employee shall not be assigned any duties that will necessitate a change in the location of his home (presently in the Dallas, Texas area). Employee shall devote substantially all his working time and efforts to the business and affairs of the Company during the full time period of this Agreement; thereafter, Employee shall devote an amount of working time and efforts as is commensurate with the duties being undertaken by Employee. Notwithstanding the foregoing, the Company acknowledges that Employee may provide consulting services to other persons and entities during the term of this Agreement provided that such consulting services (1) do not interfere with Employee's duties to the Company pursuant to this Section 3, and (ii) do not violate the provisions of Section 10 hereof. During the consulting period, Employee shall be available for telephone consultation and discrete projects as mutually agreed by the parties. Employee shall be deemed to be an employee until the expiration of the consulting period for purposes of the Employee's existing stock option agreements; for purposes of Section 10, Employee shall be deemed to be an employee through the duration of the full time period and the retainer period.
4. Compensation.
Full-Time Period. During the full time period of employment, Company shall pay Employee a monthly salary of $27,083, payable semi-monthly.
Retainer Period. During the retainer period of employment, the Company shall pay Employee a monthly payment equal to the sum of (i) $18,750 per month plus (ii) $2,500 per day of services rendered during the month to Company (with the understanding that each of the Company and Employee commits to a minimum of four days of service per month during the retainer period of employment resulting in a minimum retainer fee of $10,000 per month). The amounts payable to Employee during the retainer period of employment are payable in cash or the Company's common stock, in the Company's discretion. If paid in stock, in accordance with current Company policy, Employee shall have one (1) business day (or other mutually agreed period) after receipt of such stock to liquidate all or any portion of such stock as Employee
determines in his sole discretion and if, at the time of the final retainer period payment to Employee, the cumulative sale prices realized by Employee are less than the price used to value the stock paid to Employee, then the Company shall pay Employee such difference in cash or the Company's common stock, in the Company's discretion. To the extent Employee chooses not to sell the stock during the one (1) business day (or other mutually agreed period), then Employee shall not be entitled to any "make whole" payment, even if Employee subsequently sells the stock at a price(s) that is lower than the price used to value the stock.
Consulting Period. During the consulting period, the Company shall pay Employee at the rate of $2,500 per day of service (pro-rated as appropriate to account for partial days of service).
Stock Options. As additional compensation, the Company shall grant to Employee an option to purchase 164,000 shares of the common stock of the Company, at an exercise price of $8.50 per share, with vesting to occur pro-rata and monthly over a twelve month period commencing June 15, 2004, and on the 15th day of each month thereafter.
Nashville Home Loss Allowance Reimbursement. Company has paid to Employee a home loss reimbursement allowance as set forth in the Company's employment offer letter dated June 19, 2003. Employee shall be entitled to retain this allowance except that if (a) Employee resigns employment from the Company for any reason other than the Company does not pay the amounts it is required to pay to Employee hereunder or (b) the Company terminates Employee's employment for "Cause" (as defined under the Severance Agreement), then Employee shall within 20 days of the effective date of the employment termination pay to the Company in cash $25,000 of the home loss reimbursement allowance if the effective date of the employment separation is before July 31, 2004.
5. Expenses and Services. During the term of Employee's employment under this Agreement, Employee shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by Employee by reason of his employment, provided that such expenses are incurred and accounted for in accordance with reasonable policies and procedures established by the Company and in effect when the expenses are incurred. The Company shall furnish Employee with office space, secretarial assistance, office supplies, office equipment, and such other facilities and services as are suitable to Employee's position and adequate for the performance of his duties.
6. Confidential Information. Employee recognizes and acknowledges that Employee will have continue to have access to confidential information of the Company and its affiliated companies, including, without limitation, customer information, lists of suppliers and costs, information concerning the business and operations of the Company and its affiliated companies, and proprietary data, information, concepts and ideas (whether or not patentable or copyrightable) relating to the business of the Company and its affiliated companies, as applicable. Employee agrees not to disclose such confidential information, except as may be necessary in the performance of Employee's duties hereunder, to any person, nor use such confidential information in any way, unless Employee has received the written consent of the Company or unless such confidential information becomes public knowledge through no
wrongful act of Employee. Upon expiration of the consulting period (or earlier if requested by Company), Employee shall promptly deliver to the Company all drawings, manuals, letters, notebooks, customer lists, documents, records, equipment, files, computer disks or tapes, reports or any other materials relating to the business of the Company and its affiliated companies, and all copies, that are in Employee's possession or under Employee's control. "Confidential information" shall not include information that constitutes general skills, knowledge, and experience acquired by Employee before and/or during his employment with the Company. All intellectual property that is created, conceived, developed, and the like by Employee during the term of the full time employment period, retainer employment period, and consulting period in connection with services rendered to the Company by Employee shall be owned by the Company. Employee will render to the Company such assistance as may be reasonably necessary to evidence and protect the ownership of its intellectual property. If such assistance is required after Employee's separation from employment with the Company, reasonable compensation will be paid to Employee for such assistance.
7. Rights under Certain Plans. During the full time employment period, Employee will be entitled to participate in the insurance and employee benefit plans and programs maintained by the Company and its affiliated companies applicable to similarly situated employees on the same basis as such other employees of the Company or its affiliated companies, as applicable, subject only to the possible substitution by or on behalf of the Company or its affiliated companies of other plans or programs providing substantially similar or increased benefits for Employee. Employee will also be entitled to reasonable vacation time, with no reduction in compensation, in keeping with Employee's duties and responsibilities to the Company. Following the expiration or termination of the full time employment period, Employee shall be eligible to elect COBRA continuation benefits under the applicable benefit plans. Company shall pay Employee's COBRA premiums during the retainer period to the extent Employee elects to exercise his COBRA rights during such period. If required by applicable law, Company shall include the amount of the premiums paid on behalf of Employee in Employee's W-2 or 1099, as applicable.
8. Early Termination. Employee may terminate Employee's employment under this Agreement only if the Company does not pay the amounts it is required to pay to Employee hereunder or issue the stock required hereunder or under any of the applicable stock option agreements, provided that Employee's termination shall not release the Company from its obligations to pay all such amounts and issue such stock. Company may terminate Employee's employment under this Agreement only with Cause, as defined in the Severance Agreement.
9. Effects of Termination. If the Company terminates Employee's employment for any reason other than as permitted in Section 8 or if Employee terminates his employment because the Company does not pay the amounts it is required to pay to Employee hereunder, then Employee shall be entitled to receive the amounts and vesting rights that he would have been entitled to receive through the duration of the full time employment and retainer and consulting periods.
10. Non-competition. Employee agrees and covenants that Employee will not, during the term of his employment under this Agreement and the 12 month period following the time Employee is no longer an employee for purposes of this Agreement (as previously stated in the last sentence of Section 3):
(A) compete, directly or indirectly, with the Company's secure messaging business or care delivery services business (including the Company's e-prescription business) as they exist at the end of retainer employment period. The Company shall inform Employee in writing of changes in Company's business during the full time and retainer employment periods so that Employee may comply with this Section 10. If Employee has theretofore been conducting activities that were not in violation of this non-competition provision but became a violation of this non-competition provision because of changes in the Company's business, then Employee shall have thirty (30) days after receipt of such notice to terminate any activities that would be violation of this Section 10. For purposes of this Agreement, "Competition" shall include, without limitation, engaging in any business, whether as proprietor, partner, joint venture, employee, agent, officer, or holder of more than five percent (5%) of any class of equity ownership of a business enterprise, that is competitive with the Company's secure messaging business or care delivery services business (including the Company's e-prescription business).
(B) solicit to do, or do, competing business with any then-current customer of the Company's secure messaging business or care delivery services business (including the Company's e-prescription business) or any person that has been a customer within the six months preceding the date of Employee's separation from employment with the Company.
(C) solicit to hire, or hire, any then-current employee of the Company (including its affiliated companies), except by way of general advertising.
Although the Company and Employee have, in good faith, used their best efforts to make the non-competition covenants reasonable in all pertinent respects, and it is not anticipated, nor is it intended, by either party to this Agreement that any arbitrator or court will find it necessary to reform any non-competition covenant to make it reasonable in all pertinent respects, the Company and Employee understand and agree that if an arbitrator or court determines it necessary to reform any non-competition covenant in order to make it reasonable in all pertinent respects, damages, if any, for a breach of the non-competition covenant, as so reformed, will be deemed to accrue to the Company as and from the date of such a breach only and so far as the damages for such breach related to an action which accrued within the scope of the non-competition covenant as so reformed.
The provisions of this Section 10 shall be the only non-competition covenants applicable to Employee and all other such covenants, including, without limitation, any non-competition covenants of any stock option agreements between the Company and Employee, are no longer applicable.
11. Waiver. No waiver of any provision of this Agreement shall be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a waiver of any continuing or succeeding breach of such provision, a waiver of the provision itself, or a waiver of any right under this Agreement. No waiver shall be binding unless executed in writing by the party making the waiver.
12. Limitation of Rights. Nothing in this Agreement, except as specifically stated in this Agreement, is intended to confer any rights or remedies under or by reason of this Agreement on any persons other than the parties to it and their respective permitted successors and assigns and other legal representatives.
13. Remedies. Employee hereby agrees that a violation of the provisions of Section 6 or 10 hereof would cause irreparable injury to the Company for which it would have no adequate remedy at law. Accordingly, in the event of any such violation, the Company shall be entitled to preliminary and other injunctive relief. Any such injunctive relief shall be in addition to any other remedies to which the Company may be entitled at law or in equity, or otherwise.
14. Notice. Any consent, notice, demand, or other communication regarding any payment required or permitted hereby must be in writing to be effective and shall be deemed to have been received on the date delivered, if personally delivered, or the date received, if delivered otherwise, addressed to the applicable party at the address for such party set forth below or at such other address as such party may designate by like notice:
The Company:
Zix Corporation
2711 North Haskell Avenue
Suite 2850, LB 36
Dallas, Texas 75204-2911, Attn: General Counsel
Employee:
Daniel S. Nutkis
5252 Longvue Drive
Frisco, Texas 75034
15. Entirety and Amendments. This Agreement embodies the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings relating to the subject matter hereof. The $18,750 per month payments payable during the retainer employment period are in lieu of payments payable under the Severance Agreement. Accordingly, the Severance Agreement is hereby terminated. Employee acknowledges that other than the Company's obligation to make the payments as provided for herein, he shall not be entitled to any other compensation payments, or severance payments, or payments in lieu of notice in connection with his employment with, or separation from employment with, the Company.
16. Successors and Assigns. This Agreement will be binding upon and inure to the benefit of the parties to this Agreement and any successors in interest to the Company, but otherwise, neither this Agreement nor any rights or obligations under this Agreement may be assigned by Employee.
17. Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas (excluding its conflict of laws rules) and applicable federal law.
18. Cumulative Remedies. No remedy in this Agreement conferred upon any party is intended to be exclusive of any other benefit or remedy, and each and every such remedy shall be cumulative and shall be in addition to every other benefit or remedy given under this Agreement or now or hereafter existing at law or in equity or by statute or otherwise. No single or partial exercise by any party of any right, power, or remedy under this Agreement shall preclude any other or further exercise thereof.
19. Multiple Counterparts. This Agreement may be executed in a number of identical counterparts, each of which constitute collectively, one agreement; but in making proof of this Agreement, it shall not be necessary to produce or account for more than one counterpart.
20. Descriptive Headings. The headings, captions, and arrangements used in this Agreement are for convenience only and shall not be deemed to limit, amplify, or modify the terms of this Agreement, nor affect the meaning hereof.
21. Arbitration. The Company and the Employee agree to the resolution by binding arbitration of all claims, demands, causes of action, disputes, controversies, or other matters in question ("Claims") arising out of this Agreement or the Employee's employment (or its termination), whether sounding in contract, tort, or otherwise and whether provided by statute or common law, that the Company or its affiliated companies may have against the Employee or that the Employee may have against the Company or any and its affiliated companies, or any benefit plans of the Company or any of its affiliated companies, or any fiduciaries, administrators, and affiliates of any of such benefit plans, or their respective officers, directors, employees, or agents in their capacity as such. This agreement to arbitrate shall not limit the Company's or the Employee's right to seek equitable relief, including, but not limited to, injunctive relief and specific performance in a court of competent jurisdiction. Claims covered by this agreement to arbitrate include, but are not limited to, claims by the Employee for breach of this Agreement, wrongful termination, discrimination (based on age, race, sex, disability, national origin, or other factor), and retaliation. The only Claims otherwise within the definition of Claims that are not covered by this Section 21 are: (1) any administrative actions that the Employee is permitted to pursue under applicable law that are not precluded by virtue of the Employee having entered into this Section 21; (2) any Claim by the Employee for workers' compensation benefits or unemployment compensation benefits; or (3) any Claim by the Employee for benefits under a Company or affiliated company pension or benefit plan that provides its own non-judicial dispute resolution procedure.
Claims shall be submitted to arbitration and finally settled under the Employment Dispute Resolution Rules of the American Arbitration Association ("AAA") in effect at the time the written notice of the Claim is received. An arbitrator shall be selected in the manner provided for in the Employment Dispute Resolution Rules of the AAA, except that the parties agree that the arbitrator shall be an attorney licensed in the state where the arbitration is being conducted. If any party refuses to honor its obligations under this agreement to arbitrate, the other party may compel arbitration in either federal or state court. The arbitrator will have exclusive authority to resolve any dispute relating to the interpretation, applicability, enforceability, or formation of this agreement to arbitrate, including, but not limited to, any claim that all or part of this Agreement is void or voidable and any claim that an issue is not subject to arbitration. The arbitration will be held in Dallas County, Texas. The arbitrator shall issue a written decision that identifies the factual findings and principles of law upon which any award is based. The award and findings of such arbitrator shall be conclusive and binding upon the parties. Any and all of the arbitrator's orders, decisions, and awards may be enforceable in, and judgment upon any award rendered by the arbitrator may be confirmed and entered by, any federal or state court having jurisdiction. The Company shall pay all costs and expenses of its advisors and expert witnesses, and Employee shall pay all costs and expenses of his advisors and expert witnesses. The costs and expenses of the arbitration proceedings will be paid by the non-prevailing party or as the arbitrator otherwise determines. Discovery will be permitted to the extent directed by the arbitrator. EMPLOYEE UNDERSTANDS THAT BY AGREEING TO SUBMIT CLAIMS TO ARBITRATION, HE GIVES UP THE RIGHT TO SEEK A TRIAL BY COURT OR JURY AND THE RIGHT TO APPEAL A COURT OR JURY DECISION AND FORGOES ANY AND ALL RELATED RIGHTS HE MAY OTHERWISE HAVE UNDER FEDERAL AND STATE LAWS.
22. Authority. The Company represents and warrants to Employee that the execution, delivery and performance by the Company of this Agreement has been duly authorized by the Company and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.
Signatures
To evidence the binding effect of the covenants and agreements described above, the parties to this Agreement have executed this Agreement on the dates set forth below, to be effective as of the date first above written.
THE COMPANY:
ZIX CORPORATION
/s/ John A. Ryan --------------------------------- John A. Ryan President and Chief Executive Officer |
Date: 6-24-04
EMPLOYEE:
/s/ Daniel S. Nutkis --------------------------------- Daniel S. Nutkis Date: 6/14/04 |
Exhibit 10.2
ZIX CORPORATION
STOCK OPTION AGREEMENT
THIS STOCK OPTION AGREEMENT ("Agreement") is made and entered into as of the date set forth on the signature page attached hereto (the "Signature Page") with respect to the stock options granted by Zix Corporation, a Texas corporation (the "Company"), to the Optionee ("Optionee") listed on the signature page hereto.
WHEREAS, the Company wishes to recognize the contributions of the Optionee to the Company and to encourage the Optionee's sense of proprietorship in the Company by owning the Common Stock, par value $.01 per share (the "Common Stock"), of the Company;
NOW, THEREFORE, in consideration of the mutual agreements and covenants contained herein, the Company hereby grants to the Optionee a non-qualified stock option ("Option") to purchase up to the total number of shares of the Common Stock set forth on the Signature Page at the price per share (the "Option Price") as set forth on the Signature Page on the terms and conditions and subject to the restrictions as set forth in this Agreement and the provisions of the applicable Zix Corporation stock option plan (which is incorporated herein by reference) (the "Plan"), which is referenced on the Signature Page. All defined terms contained herein shall have the meanings ascribed to them in the Plan, except as otherwise provided herein.
1. DEFINITIONS.
a. Disability. "Disability" shall mean any medically determinable physical or mental impairment that, in the opinion of the Committee, based upon medical reports and other evidence satisfactory to the Committee, can reasonably be expected to prevent the Optionee from performing substantially all of his or her customary duties of employment (with or without reasonable accommodation) for a continuous period of not less than 12 months.
b. Resignation. "Resignation" shall mean the voluntary termination by the Optionee of his or her employment relationship with the employing Subsidiary and, if applicable, Company under circumstances other than voluntary Retirement.
c. Retirement. "Retirement" shall mean the termination of Optionee's employment in accordance with the requirements of a written retirement plan, policy or rule of the Company that has been duly adopted by the Company or employing Subsidiary, as applicable.
2. TERM OF OPTION. The term of this Option shall expire on the expiration date set forth in the Signature Page (the "stated term"), except as such term may be otherwise shortened by the other provisions of the Plan or this Agreement.
3. EXERCISE OF OPTION.
a. Exercise. This Option shall become exercisable in increments as set forth in the Signature Page. Except as provided in the Plan, the Option shall not be exercisable unless Optionee shall, at the time of exercise, be an employee of the Company or a Subsidiary, and once the Option has become exercisable with respect to a certain number of shares as provided above, it shall thereafter be exercisable as to all of that number of shares, or as to any part thereof, until expiration or termination of this Option. However, this Option may not be exercised as to less than 100 shares at any one time (or the remaining shares then purchasable under this Option, if less than 100 shares).
b. Adjustment. In the event there is any adjustment to the Common Stock the Board of Directors or Committee shall make such adjustment as it deems appropriate to the number of shares subject to the Option or to the Option Price, or both.
c. Method of Exercise. This Option may be exercised only by written notice (the "Exercise Notice") by the Optionee to the Company at its principal executive office. The Exercise Notice shall be deemed given when deposited in the U. S. mails, postage prepaid, addressed to the Company at its principal executive office, or if given other than by deposit in the U.S. mails, when delivered in person to an officer of the Company at that office. The date of exercise of this Option (the "Exercise Date") shall be the date of the postmark if the notice is mailed or the date received if the notice is delivered other than by mail. The Exercise Notice shall state the number of shares in respect of which this Option is being exercised and, if the shares for which this Option is being exercised are to be evidenced by more than one stock certificate, the denominations in which the stock certificates are to be issued. The Exercise Notice shall be signed by the Optionee and shall include the complete address of such person, together with such person's social security number.
This Option may be exercised either by tendering cash in the amount of the Option Price or, with the Company's consent, by tendering shares of Common Stock (which may include shares previously acquired upon exercise of options granted under the Plan). The Exercise Notice shall be accompanied by payment of the aggregate Option Price of the shares purchased by cash, a certified cashier's check or, at the Company's option, by delivery of shares of Common Stock having a Fair Market Value on the date immediately preceding the exercise date equal to the Option Price.
If the shares to be purchased are covered by an effective registration
statement under the Securities Act of 1933, as amended, any option granted under
the Plan may be exercised by a broker-dealer acting on behalf of an Optionee if
(a) the broker-dealer has received from the Optionee or the Company a fully- and
duly-endorsed agreement evidencing such option, together with instructions
signed by the Optionee requesting the Company to deliver the shares of Common
Stock subject to such option to the broker-dealer on behalf of the Optionee and
specifying the account into which such shares should be deposited, (b) adequate
provision has been made with respect to the payment of any withholding taxes due
upon such exercise, and (c) the broker-dealer and the Optionee have otherwise
complied with Section 220.3(e)(4) of Regulation T, 12 CFR Part 220, or any
successor provision.
The certificates for shares of Common Stock as to which this Option shall
have been so exercised shall be registered in the name of the Optionee and shall
be delivered to the Optionee at the address specified in the Exercise Notice. An
option exercise shall be valid only if the Optionee makes payment or other
arrangements relating to the withholding tax obligations discussed in Paragraph
8. In the event the person exercising this Option is a transferee of the
Optionee by will or under the laws of descent and distribution, the Exercise
Notice shall be accompanied by appropriate proof of the right of such transferee
to exercise this Option.
4. TERMINATION OF OPTION.
In the event an Optionee ceases to be an employee of either the Company or a Subsidiary of the Company due to death, Retirement, Resignation, Disability or termination by the Company for any reason other than "cause" (such five events each being a "Qualified Termination"), this Option may be exercised by the Optionee or his or her estate, personal representative or beneficiary to the fullest extent that the Optionee was entitled to exercise the same on the day immediately prior to such termination (i) at any time within the one-year period commencing on the day next following such termination if such termination is due to the death of the Optionee; (ii) at any time within the thirty-day period commencing on the day next following the effective date of such termination if such termination is due to the Resignation of the Optionee; or (iii) at any time within the six-month period commencing on the day next following such termination in the case of any other Qualified Termination (or in any such case in (i), (ii) or (iii) above, if shorter, only for the remaining stated term of this Option). In the event that the Optionee's employment is terminated for any reason other than a Qualified Termination, this Option shall automatically expire simultaneously with such termination. For purposes of this Paragraph, "cause" shall have the meaning given such term in the Severance Agreement, dated July 1, 2003, between Optionee and the Company. For purposes of this Agreement, Optionee shall be considered to be an employee of the Company until the expiration of the "consulting period," as such term is defined in Section 8 of the Employment Agreement, dated June 1, 2004, between the Company and Optionee.
After the Optionee's death, this Option shall be exercisable only by the executor or administrator of the Optionee's estate, or if the Optionee's estate is not in administration, by the person or persons to whom the Optionee's rights shall have passed by the Optionee's will or under the laws of descent and distribution of the state where the Optionee was domiciled at the date of death.
5. NO RIGHTS AS SHAREHOLDER. Neither the Optionee nor any person claiming under or through the Optionee shall be or have any rights or privileges of a shareholder of the Company in respect of any of the shares issuable upon the exercise of this Option, unless and until certificates representing such shares shall have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company).
6. STATE AND FEDERAL SECURITIES REGULATION. No shares shall be issued by the Company upon the exercise of this Option unless and until any then-applicable requirements of state and federal laws and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel. The Company may suspend for a reasonable period or periods the time during which this Option may be exercised if, in the opinion of the Company, such suspension is required to enable the Company to remain in compliance with regulatory requirements relating to the issuance of shares of Common Stock subject to this Option. This Option is subject to the requirement that, if at any time the Company shall determine, in its discretion, that the listing, registration or qualification of the shares of common stock subject to this Option upon any securities exchange or under any state or federal law, or the consent or approval of any government regulatory body, is necessary or desirable as a condition of, or in connection with, the granting or exercise of this Option or the issue or purchase of shares under this Option, this Option may not be exercised in whole or in part until such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company. The Company shall be under no obligation to effect or obtain any such listing, registration, qualification, consent or approval if the Company shall determine, in its discretion, that such action would not be in the best interest of the Company. The Company shall not be liable for damages due to a delay in the delivery or issuance of any stock certificates for any reason whatsoever, including, but not limited to, a delay caused by listing, registration or qualification of the shares of Common Stock subject to an option upon any securities exchange or under any federal or state law or the effecting or obtaining of any consent or approval of any governmental body with respect to the granting or exercise of this Option or the issue or purchase of shares under this Option.
7. MODIFICATION OF OPTIONS. At any time and from time-to-time the Committee may execute an instrument providing for modification, extension, or renewal of any outstanding option, provided that no such modification, extension or renewal shall impair this Option in any respect without the written consent of the holder of this Option.
8. WITHHOLDING OF TAXES. The Company may make such provisions and take such steps as it may deem necessary or appropriate for the withholding of any taxes which the Company or any Subsidiary is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign, to withhold in connection with any option, including, but not limited to, the withholding of the issuance of all or any portion of the shares of Common Stock subject to this Option until the Optionee reimburses the Company or the applicable Subsidiary for the amount the Company or the applicable Subsidiary is required to withhold with respect to such taxes, canceling any portion of the issuance in an amount sufficient to reimburse the Company or the applicable Subsidiary for the amount it is required to so withhold, or taking any other action reasonably required to satisfy the withholding obligation of the Company or the applicable Subsidiary.
9. CONTINUED EMPLOYMENT NOT PRESUMED. Nothing in this Agreement, the Plan or any document describing it nor the grant of an option shall give the Optionee the right to continue in employment with the Company or any of its Subsidiaries or affect the right of the Company or a Subsidiary to terminate the employment of the Optionee with or without cause.
10. NON-COMPETITION COVENANTS.
a. The provisions of this subparagraph a. shall apply both during normal working hours and at all other times including, but not limited to, nights, weekends and vacation time, while Optionee is employed by the Company or any Subsidiary. Optionee shall not directly or indirectly (i) engage in any employment, business, or activity that is competitive with the business of the Company or any Subsidiary, (ii) assist any other person or organization in competing with, or in preparing to engage in competition with, the business of the Company or any Subsidiary. Direct competition shall include, but not be limited to, the design, development, production, promotion or sale of products, software, or services competitive with those of the Company or any Subsidiary. In addition, Optionee shall not directly or indirectly (i) engage in any employment, business, or activity that is competitive with either (A) the proposed business of the Subsidiary that employs Optionee ("Employing Subsidiary") or (B) any proposed business of any of the Company's other Subsidiaries (the "Non-Employing Subsidiaries") of which Optionee has actual knowledge, or (ii) assist any other person or organization in competing with, or in preparing to engage in competition with, either (A) the proposed business of the Employing Subsidiary or (B) any proposed business of any Non-Employing Subsidiary of which Optionee has actual knowledge.
b. The provisions of this subparagraph b. shall apply during Optionee's employment with the Company or any Subsidiary and for a period of six months after Optionee ceases to be employed by the Company or any Subsidiary. Optionee shall not directly or indirectly solicit to conduct any Competitive Business with, or conduct any Competitive Business with, any (i) then-current customer of the Employing Subsidiary or (ii) any person that has been a customer of the Employing Subsidiary within the six months prior to the time of Optionee's separation from employment. The phrase "Competitive Business" means the line(s) of business(es) conducted by the Employing Subsidiary.
c. The provisions of this subparagraph c. shall apply during Optionee's employment with the Company or any Subsidiary and for a period of 12 months after Optionee's separation from employment. Optionee shall not directly or indirectly solicit to hire, or cause to be hired, any employee of the Company or any Subsidiary as an employee or agent of, or consultant to, any business enterprise that Optionee is associated with.
d. Each non-competition covenant of Optionee contained in the preceding provisions of this Paragraph 10 (the "non-competition covenant") shall be construed as an agreement independent of any other provision of this Agreement and the existence of any claim or cause of action of Optionee against the Company or any Subsidiary, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company or any Subsidiary of such non-competition covenant.
e. The Company and Optionee have in good faith used their best efforts to make each non-competition covenant contained in the preceding provisions of this Paragraph 10 reasonable in both scope and in duration. It is not anticipated, nor is it intended, by either party
to this Agreement that any court or other tribunal having jurisdiction over the matter will find it necessary to reform any non-competition covenant to make it reasonable in both scope and in duration, or otherwise. If any non-competition covenant is deemed by a tribunal having jurisdiction over the matter to be unlawful or unenforceable, such provision will be deemed severable from this Agreement and such provision will be limited or eliminated to the minimum extent necessary so that the remaining provisions of this Agreement shall otherwise remain in full force and effect and be enforceable. Furthermore, in lieu of such unlawful or unenforceable provision, there shall be added automatically as part of this Agreement a provision as similar in terms as may be possible and be enforceable.
f. Optionee is agreeing to the provisions of this Paragraph 10 in consideration of the grant of this Option. The provisions of this Paragraph 10 shall be valid and enforceable by the Company and its Subsidiaries, regardless of whether or not any of this Option granted hereunder actually becomes exercisable, or whether or not Optionee actually exercises any rights under this Option. In the event of any conflict or inconsistency between any provision of this Paragraph 10 and any similar or analogous provision of any other agreement (either currently in effect or that may be entered into in the future) between Optionee, on the one hand, and the Company or any Subsidiary, on the other hand, whichever provision is most favorable to the Company or such Subsidiary shall govern.
11. OPTION ISSUED PURSUANT TO PLAN. This Option is issued pursuant to and subject to the terms and conditions and the restrictions as set forth in the Plan, and in the event of any inconsistency, the provisions of the Plan shall govern, provided that no amendment shall be made to the Plan subsequent to the date hereof that impairs the Optionee's rights under this Option without the Optionee's written consent.
12. NO LIABILITY OF OPTION. This Option is not liable for or subject to, in whole or in part, the debts, contracts, liabilities or torts of the Optionee nor shall it be subject to garnishment, attachment, execution, levy or other legal or equitable process.
13. NO ASSIGNMENT. This Option is not transferable otherwise than by will or the laws of descent and distribution, and is exercisable during the Optionee's lifetime only by Optionee. Without limiting the generality of the foregoing, this Option may not be assigned, transferred (except as aforesaid), pledged or hypothecated in any way (whether by operation of law or otherwise), and shall not be subject to execution, attachment, or similar process, without the prior written consent of the Company. Any attempted assignment, transfer, pledge, or hypothecation contrary to the provisions hereof shall be void and ineffective for all purposes.
14. GOVERNING LAW. This Agreement has been executed in, and shall be deemed to be performable in, Dallas, Dallas County, Texas. The parties agree that this Agreement shall be governed by and construed in accordance with the laws of the State of Texas (excluding its conflict of laws rules). The parties further agree that the courts of the State of Texas, and any courts whose jurisdiction is derivative on the jurisdiction of the courts of the State of Texas, shall have personal jurisdiction over all parties to this Agreement.
15. ENTIRE AGREEMENT. By signing the Signature Page, the Optionee agrees to the terms of this Option. Except for the Plan, this Agreement constitutes the entire agreement between the parties pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations and understandings of the parties. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the party to be charged therewith. No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver.
16. NOTICE. Other than any Exercise Notice, any notice required or permitted to be given under the Plan or this Agreement shall be in writing and delivered in person or sent by registered or certified mail, return receipt requested, first-class postage prepaid, (i) if to the Optionee, at the address shown on the books and records of the Company or at the Optionee's place of employment, or (ii) if to the Company, at 2711 N. Haskell Avenue, Suite 2300, LB 36, Dallas, Texas 75204-2960: Attention: Treasurer, or any other address that may be given by either party to the other party by notice pursuant to this Paragraph. Any notice other than any Exercise Notice, if sent by registered or certified mail, shall be deemed to have been given when received.
ZIX CORPORATION
By: /s/ Bradley C. Almond --------------------------------- Bradley C. Almond Vice President, Chief Financial Officer and Treasurer |
[ZIXCORP LOGO]
Signature Page
To
Zix Corporation Stock Option Agreement
Effective Date of Grant: JUNE 1, 2004
Name of Optionee: NUTKIS, DAN No. of Shares: 164,000 Exercise Price: $8.50 Name of Plan: ZIX CORPORATION 2004 STOCK OPTION PLAN Expiration Date: MAY 31, 2009 |
Vesting Schedule:
Date Upon Which Right Number of Shares To Purchase Accrues ---------------- ------------------- 13,666 15-JUN-04 13,666 15-JUL-04 13,666 15-AUG-04 13,666 15-SEP-04 13,667 15-OCT-04 13,667 15-NOV-04 13,667 15-DEC-04 13,667 15-JAN-05 13,667 15-FEB-05 13,667 15-MAR-05 13,667 15-APR-05 13,667 15-MAY-05 |
/s/ Dan Nutkis Date: 7/30/04 ----------------------------- Optionee Signature |
Sign and return to:
ZixCorporation, 2711 N. Haskell Avenue, Suite 2300, Dallas, Texas 75204-2960
Attn: Human Resources Department
Exhibit 10.3
ZIX CORPORATION
OUTSIDE DIRECTOR
STOCK OPTION AGREEMENT
(1999 DIRECTORS' STOCK OPTION PLAN, AS AMENDED)
Effective Date of Grant Expiration Date
January 2, 2004 January 1, 2014
TO: _________________________________________ ("Optionee")
WHEREAS, Zix Corporation (the "Company") wishes to recognize the contributions of the Optionee to the Company and to encourage the Optionee's sense of proprietorship in the Company by owning the common stock, par value $.01 per share (the "Common Stock"), of the Company;
NOW, THEREFORE, in consideration of the mutual agreements and covenants contained herein, the Company hereby grants to the Optionee a nonqualified stock option ("Option") to purchase up to a total of 83,292 shares of the Common Stock at a price per share of $9.86 (the "Option Price") on the terms and conditions and subject to the restrictions as set forth in this Agreement and the provisions in the Zix Corporation 1999 Directors' Stock Option Plan, as amended and restated as of August 1, 2002 (which is incorporated herein by reference) (the "Plan"). All defined terms contained herein shall have the meanings ascribed to them in the Plan, except as otherwise provided herein.
1. DEFINITIONS.
a. Acquiring Person. An "Acquiring Person" shall mean any person (including any "person" as such term is used in Sections 13(d)(3) or 14(d)(2) of the Exchange Act that, together with all Affiliates and Associates of such person, is the beneficial owner (as the term "beneficial owner" is defined under Rule 13d-3 or any successor rule or regulation promulgated under the Exchange Act) of 10% or more of the outstanding Common Stock. The term "Acquiring Person" shall not include the Company, any majority-owned subsidiary of the Company, any employee benefit plan of the Company or a majority-owned subsidiary of the Company, or any person to the extent such person is holding Common Stock for or pursuant to the terms of any such plan. For the purposes of this Agreement, a person who becomes an Acquiring Person by acquiring beneficial ownership of 10% or more of the Common Stock at any time after the date of this Agreement shall continue to be an Acquiring Person whether or not such person continues to be the beneficial owner of 10% or more of the outstanding Common Stock.
b. Affiliate and Associate. "Affiliate" and "Associate" shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act in effect on the date of this Agreement.
c. Cause. "Cause" shall mean the willful engaging by the Optionee in illegal conduct or gross misconduct that is materially and demonstrably injurious to the Company or its subsidiaries. For purposes of this definition, no act or failure to act on the part of the Optionee shall be considered willful unless it is done, or omitted to be done, by the Optionee in bad faith or without reasonable belief that the Optionee's action or omission was in the best interest of the Company.
d. Change in Control. A "Change in Control" of the Company shall have occurred if during the term of this Agreement, any of the following events shall occur:
(i) The Company is merged, consolidated or reorganized into or with another corporation or other legal person and as a result of such merger, consolidation or reorganization, the Company or its shareholders or Affiliates immediately before such transaction beneficially own, immediately after or as a result of such transaction, equity securities of the surviving or acquiring corporation or such corporation's parent corporation possessing less than fifty-one percent (51%) of the voting power of the surviving or acquiring person or such person's parent corporation;
(ii) The Company sells all or substantially all of its assets to any other corporation or other legal person and as a result of such sale, the Company or its shareholders or Affiliates immediately before such transaction beneficially own, immediately after or as a result of such transaction, equity securities of the surviving or acquiring corporation or such corporation's parent corporation possessing less than fifty-one percent (51%) of the voting power of the surviving or acquiring person or such person's parent corporation (provided that this provision shall not apply to a registered public offering of securities of a subsidiary of the Company, which offering is not part of a transaction otherwise a part of or related to a Change in Control);
(iii) Any Acquiring Person has become the beneficial owner (as the term "beneficial owner" is defined under Rule 13d-3 or any successor rule or regulation promulgated under the Exchange Act) of securities which, when added to any securities already owned by such person, would represent in the aggregate 35% or more of the then outstanding securities of the Company which are entitled to vote to elect any class of directors;
(iv) If, at any time, the Continuing Directors then serving on the Board of Directors of the Company cease for any reason to constitute at least a majority thereof; or
(v) Any occurrence that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A or any successor rule or regulation promulgated under the Exchange Act.
e. Continuing Director. A "Continuing Director" shall mean a director of the Company who (i) is not an Acquiring Person or an Affiliate or Associate thereof, or a representative of an Acquiring Person or nominated for election by an Acquiring Person, and (ii) was either a member of the Board of Directors of the Company on the date of this Agreement or subsequently became a director of the Company and whose initial election or initial nomination for election by the Company's shareholders was approved by a majority of the Continuing Directors then on the Board of Directors of the Company.
f. Exchange Act. "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended.
g. Option Shares. "Option Shares" shall mean the Common Stock shares received upon exercise of the Option.
h. Transfer. "Transfer" (or any derivative thereof) means a direct or indirect assignment, sale, transfer, license, lease, pledge, encumbrance, hypothecation or execution, attachment or similar process.
2. TERM OF OPTION. The term of the Option shall expire at 12:00 midnight on the date set forth in the upper right hand corner on page 1 of this Agreement (the "Expiration Date" or "stated term"), except as such term may be otherwise shortened by the other provisions of the Plan or this Agreement.
3. EXERCISE OF OPTION.
a. Exercise. The Option shall become exercisable in increments as follows:
Date Upon Which Right Number of Shares To Purchase Accrues ---------------- --------------------- 27,764 January 2, 2005 27,764 January 2, 2006 27,764 January 2, 2007 |
Except as provided in the Plan, the Option shall not be exercisable unless the Optionee is, at the time of exercise, a director of the Company, and once the Option has become exercisable with respect to a certain number of shares as provided above, it shall thereafter be exercisable as to all of that number of shares, or as to any part thereof, until the expiration or termination of the Option. However, the Option may not be exercised as to less than 100 shares at any one time (or the remaining shares then purchasable under the Option, if less than 100 shares).
b. Adjustment. In the event there is any adjustment to the Common Stock pursuant to Section 9 of the Plan, the Board of Directors or Committee shall make such adjustment as it deems appropriate to the number of shares subject to the Option or to the exercise price listed above, or
both. If a merger, consolidation, sale of shares, or similar transaction involving the Company, on the one hand, and one or more persons, on the other hand, with respect to the Company occurs, and, as a part of such transaction, shares of stock, other securities, cash or property shall be issuable or deliverable in exchange for Common Stock, then the Optionee shall be entitled to purchase or receive (in lieu of the Option Shares that the Optionee would otherwise be entitled to purchase or receive hereunder), the number of shares of stock, other securities, cash or property to which that number of shares of Common Stock would have been entitled in connection with such transaction (and, at an aggregate exercise price equal to the aggregate exercise price hereunder that would have been payable if that number of shares of Common Stock had been purchased on the exercise of the Option immediately before the consummation of the transaction).
c. Accelerated Vesting. The Option shall become fully exercisable (i) upon the occurrence of a Change of Control, if the Optionee is still a director of the Company on the date of the occurrence of the Change of Control or (ii) if the Optionee is removed from the Board of Directors of the Company by a vote of the shareholders other than for Cause. If either of such events occurs, the Option may be exercised at any time or times thereafter until the expiration or termination of the Option.
d. Method of Exercise. To exercise the Option with respect to any vested shares of Common Stock hereunder, the Optionee shall provide written notice (the "Exercise Notice") to the Company at its principal executive office. The Exercise Notice shall be deemed given when deposited in the U. S. mails, postage prepaid, addressed to the Company at its principal executive office, or if given other than by deposit in the U.S. mails, when delivered in person to an officer of the Company at that office. The date of exercise of the Option (the "Exercise Date") shall be the date of the postmark if the notice is mailed or the date received if the notice is delivered other than by mail. The Exercise Notice shall state the number of shares in respect of which the Option is being exercised and, if the shares for which the Option is being exercised are to be evidenced by more than one stock certificate, the denominations in which the stock certificates are to be issued. The Exercise Notice shall be signed by the Optionee and shall include the complete address of such person, together with such person's social security number. If the Option is exercised in full, the Optionee shall surrender this Agreement to the Company for cancellation. If the Option is exercised in part, the Optionee shall surrender this Agreement to the Company so that the Company may make appropriate notation hereon or cancel this Agreement and issue a new agreement representing the unexercised portion of the Option.
At the time of exercise, the Optionee shall pay to the Company the Option Price times the number of vested shares as to which the Option is being exercised. The Optionee shall make such payment by delivering (a) cash, (b) a certified cashier's check or (c) at the Committee's election, any other consideration that the Committee determines is consistent with the Plan and applicable law. If the shares to be purchased are covered by an effective registration statement under the Securities Act of 1933, as amended, the Option may be exercised by a broker-dealer acting on behalf of the Optionee if (a) the broker-dealer has received from the Optionee or the Company a fully- and duly-endorsed agreement evidencing such Option, together with instructions signed by the Optionee requesting the Company to deliver the shares of Common Stock subject to such Option to the broker-dealer on behalf of the Optionee and specifying the account into which such shares should be
deposited, (b) adequate provision has been made with respect to the payment of any withholding taxes due upon such exercise, and (c) the broker-dealer and the Optionee have otherwise complied with Section 220.3(e)(4) of Regulation T, 12 CFR Part 220, or any successor provision.
The certificates for shares of Common Stock as to which the Option shall have been so exercised shall be registered in the name of the Optionee and shall be delivered to the Optionee at the address specified in the Exercise Notice. If applicable, the stock certificates shall contain an appropriate legend referencing the transfer restrictions noted in Subparagraph 3.d. An Option exercise shall be valid only if the Optionee makes payment or other arrangements relating to the withholding tax obligations discussed in Paragraph 11. In the event the person exercising the Option is a transferee of the Optionee by will or under the laws of descent and distribution, the Exercise Notice shall be accompanied by appropriate proof of the right of such transferee to exercise the Option.
4. WHO MAY EXERCISE OPTION. The Option shall be exercisable during the lifetime of the Optionee only by the Optionee. To the extent exercisable after the Optionee's death, the Option shall be exercised only by a person who has obtained the Optionee's rights under the Option by will or under the laws of descent and distribution.
5. TERMINATION OF OPTION. If the Optionee's directorship is terminated by a vote of the shareholders or directors for Cause, the Option shall automatically expire (and shall not thereafter be exercisable) simultaneously with such termination. If the Optionee's directorship terminates for any other reason, the Option shall be exercisable with respect to the shares that were vested as of the termination date until the first anniversary of the date that the Optionee ceased to be a director of the Company (or, if the remaining stated term of the Option is shorter, until 12:00 midnight on the Expiration Date). The Option shall not thereafter be exercisable.
6. NO RIGHTS AS SHAREHOLDER. Neither the Optionee nor any person claiming under or through the Optionee shall be or have any rights or privileges of a shareholder of the Company in respect of any of the shares issuable upon the exercise of the Option, unless and until certificates representing such shares shall have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company).
7. STATE AND FEDERAL SECURITIES REGULATION. No shares shall be issued by the Company upon the exercise of the Option unless and until any then-applicable requirements of state and federal laws and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel. The Company may suspend for a reasonable period or periods the time during which the Option may be exercised if, in the opinion of the Company, such suspension is required to enable the Company to remain in compliance with regulatory requirements relating to the issuance of shares of Common Stock subject to the Option. The Option is subject to the requirement that, if at any time the Company shall determine, in its discretion, that the listing, registration or qualification of the shares of Common Stock subject to the Option upon any securities exchange or under any state or federal law, or the consent or approval of any government regulatory body, is necessary or desirable as a condition of, or in connection with, the granting or exercise of the Option or the issue or purchase of shares under the Option, the Option may not be exercised in whole or in part until such
listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company. The Company shall be under no obligation to effect or obtain any such listing, registration, qualification, consent or approval if the Company shall determine, in its discretion, that such action would not be in the best interest of the Company. The Company shall not be liable for damages due to a delay in the delivery or issuance of any stock certificates for any reason whatsoever, including, but not limited to, a delay caused by listing, registration or qualification of the shares of Common Stock subject to an option upon any securities exchange or under any federal or state law or the effecting or obtaining of any consent or approval of any governmental body with respect to the granting or exercise of the Option or the issue or purchase of shares under the Option.
8. MODIFICATION OF OPTIONS. At any time and from time-to-time, the Committee may execute an instrument providing for modification, extension or renewal of the Option, provided that no such modification, extension or renewal shall (i) impair the Option in any respect without the written consent of the holder of the Option or (ii) conflict with the provisions of Rule 16b-3 under the Exchange Act. Except as provided in the preceding sentence, no supplement, modification or amendment of this Agreement or waiver of any provision of this Agreement shall be binding unless executed in writing by all parties to this Agreement. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision of this Agreement (regardless of whether similar), nor shall any such waiver constitute a continuing waiver unless otherwise expressly provided.
9. CONTINUED DIRECTORSHIP NOT PRESUMED. Nothing in this Agreement, the Plan or any document describing it nor the grant of an option shall give the Optionee the right to continue as a director of the Company.
10. OPTION ISSUED PURSUANT TO PLAN. The Optionee accepts the Option herein subject to all the provisions of the Plan, which are incorporated herein, including the provisions that authorize the Committee to administer and interpret the Plan and provide that the Committee's determinations and interpretations with respect to the Plan are final and conclusive and binding on all persons affected thereby.
11. TAX WITHHOLDING. Any provision of this Agreement to the contrary notwithstanding, the Company may take such steps as it deems necessary or desirable for the withholding of any taxes that it is required by law or regulation of any governmental authority, federal, state or local, domestic or foreign, to withhold in connection with any of the shares of Common Stock subject hereto.
12. NO LIABILITY OF OPTION. The Option is not liable for or subject to, in whole or in part, the debts, contracts, liabilities or torts of the Optionee nor shall it be subject to garnishment, attachment, execution, levy or other legal or equitable process.
13. NO ASSIGNMENT. The Option is not Transferable otherwise than by will or the laws of descent and distribution, and is exercisable during the Optionee's lifetime only by him or her. Without limiting the generality of the foregoing, the Option may not be Transferred (except as aforesaid), and shall not be subject to execution, attachment or similar process, without the prior written consent of the Company. Any attempted Transfer contrary to the provisions hereof shall be void and ineffective for all purposes.
14. GOVERNING LAW. This Agreement has been executed in, and shall be deemed to be performable in, Dallas, Dallas County, Texas. The parties agree that this Agreement shall be governed by and construed in accordance with the laws of the State of Texas (excluding its conflict of laws rules). The parties further agree that the courts of the State of Texas, and any courts whose jurisdiction is derivative on the jurisdiction of the courts of the State of Texas, shall have personal jurisdiction over all parties to this Agreement.
15. ENTIRE AGREEMENT. Except for the Plan, this Agreement constitutes the entire agreement between the parties pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations and understandings of the parties. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the party to be charged therewith. No waiver of any of the provisions of this Agreement shall be deemed, or shall, constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver.
16. DUPLICATE ORIGINALS. Duplicate originals of this document shall be executed by both the Company and the Optionee, each of which shall retain one duplicate original.
17. NOTICE. Other than any Exercise Notice, any notice required or permitted to be given under the Plan or this Agreement shall be in writing and delivered in person or sent by registered or certified mail, return receipt requested, first-class postage prepaid, (i) if to the Optionee, at the address shown on the books and records of the Company or at the Optionee's place of employment, or (ii) if to the Company, at 2711 N. Haskell Avenue, Suite 2300, Dallas, Texas 75204-2960, Attention: Vice President Finance & Administration, or any other address that may be given by either party to the other party by notice pursuant to this Paragraph 17. Any notice other than any Exercise Notice, if sent by registered or certified mail, shall be deemed to have been given when received.
18. MISCELLANEOUS.
a. The Option herein is intended to be a nonqualified stock option under applicable tax laws, and it is not to be characterized or treated as an incentive stock option under such laws.
b. Subject to the limitations herein on the Transferability by the Optionee of the Option and any shares of Common Stock, this Agreement shall be binding upon and inure to the benefit of the representatives, executors, successors or beneficiaries of the parties hereto.
c. If any provision of this Agreement is declared or found to be illegal, unenforceable or void, in whole or in part, then the parties shall be relieved of all obligations arising under such provision, but only to the extent that it is illegal, unenforceable or void, it being the intent and agreement of the parties that this Agreement shall be deemed amended by modifying such provision to the extent necessary to make it legal and enforceable while preserving its intent or, if that is not possible, by substituting therefor another provision that is legal and enforceable and achieves the same objectives.
d. All section titles and captions in this Agreement are for convenience only, shall not be deemed part of this Agreement, and in no way shall define, limit, extend or describe the scope or intent of any provisions of this Agreement.
e. The parties shall execute all documents, provide all information and take or refrain from taking all actions as may be necessary or appropriate to achieve the purposes of this Agreement.
f. No failure by any party to insist upon the strict performance of any covenant, duty, agreement or condition of this Agreement or to exercise any right or remedy consequent upon a breach thereof shall constitute a waiver of any such breach or any other covenant, duty, agreement or condition.
g. In addition to all other rights or remedies available at law or in equity, the Company shall be entitled to injunctive and other equitable relief to prevent or enjoin any violation of the provisions of this Agreement.
ZIX CORPORATION
By: /s/ Bradley C. Almond -------------------------------------- Bradley C. Almond Vice President Finance & Administration |
OPTIONEE:
Exhibit 10.4
ZIX CORPORATION
OUTSIDE DIRECTOR
STOCK OPTION AGREEMENT
(2004 DIRECTORS' STOCK OPTION PLAN)
Effective Date of Grant Expiration Date
May 6, 2004 May 5, 2014
TO: Antonio R. Sanchez III ("Optionee")
WHEREAS, Zix Corporation (the "Company") wishes to recognize the contributions of the Optionee to the Company and to encourage the Optionee's sense of proprietorship in the Company by owning the common stock, par value $.01 per share (the "Common Stock"), of the Company;
NOW, THEREFORE, in consideration of the mutual agreements and covenants contained herein, the Company hereby grants to the Optionee a nonqualified stock option ("Option") to purchase up to a total of 50,000 shares of the Common Stock at a price per share of $8.89 (the "Option Price") on the terms and conditions and subject to the restrictions as set forth in this Agreement and the provisions in the Zix Corporation 2004 Directors' Stock Option Plan (which is incorporated herein by reference) (the "Plan"). All defined terms contained herein shall have the meanings ascribed to them in the Plan, except as otherwise provided herein.
1. DEFINITIONS.
a. Acquiring Person. An "Acquiring Person" shall mean any person (including any "person" as such term is used in Sections 13(d)(3) or 14(d)(2) of the Exchange Act that, together with all Affiliates and Associates of such person, is the beneficial owner (as the term "beneficial owner" is defined under Rule 13d-3 or any successor rule or regulation promulgated under the Exchange Act) of 10% or more of the outstanding Common Stock. The term "Acquiring Person" shall not include the Company, any majority-owned subsidiary of the Company, any employee benefit plan of the Company or a majority-owned subsidiary of the Company, or any person to the extent such person is holding Common Stock for or pursuant to the terms of any such plan. For the purposes of this Agreement, a person who becomes an Acquiring Person by acquiring beneficial ownership of 10% or more of the Common Stock at any time after the date of this Agreement shall continue to be an Acquiring Person whether or not such person continues to be the beneficial owner of 10% or more of the outstanding Common Stock.
b. Affiliate and Associate. "Affiliate" and "Associate" shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act in effect on the date of this Agreement.
c. Cause. "Cause" shall mean the willful engaging by the Optionee in illegal conduct or gross misconduct that is materially and demonstrably injurious to the Company or its subsidiaries. For purposes of this definition, no act or failure to act on the part of the Optionee shall be considered willful unless it is done, or omitted to be done, by the Optionee in bad faith or without reasonable belief that the Optionee's action or omission was in the best interest of the Company.
d. Change in Control. A "Change in Control" of the Company shall have occurred if during the term of this Agreement, any of the following events shall occur:
(i) The Company is merged, consolidated or reorganized into or with another corporation or other legal person and as a result of such merger, consolidation or reorganization, the Company or its shareholders or Affiliates immediately before such transaction beneficially own, immediately after or as a result of such transaction, equity securities of the surviving or acquiring corporation or such corporation's parent corporation possessing less than fifty-one percent (51%) of the voting power of the surviving or acquiring person or such person's parent corporation;
(ii) The Company sells all or substantially all of its assets to any other corporation or other legal person and as a result of such sale, the Company or its shareholders or Affiliates immediately before such transaction beneficially own, immediately after or as a result of such transaction, equity securities of the surviving or acquiring corporation or such corporation's parent corporation possessing less than fifty-one percent (51%) of the voting power of the surviving or acquiring person or such person's parent corporation (provided that this provision shall not apply to a registered public offering of securities of a subsidiary of the Company, which offering is not part of a transaction otherwise a part of or related to a Change in Control);
(iii) Any Acquiring Person has become the beneficial owner (as the term "beneficial owner" is defined under Rule 13d-3 or any successor rule or regulation promulgated under the Exchange Act) of securities which, when added to any securities already owned by such person, would represent in the aggregate 35% or more of the then outstanding securities of the Company which are entitled to vote to elect any class of directors;
(iv) If, at any time, the Continuing Directors then serving on the Board of Directors of the Company cease for any reason to constitute at least a majority thereof; or
(v) Any occurrence that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A or any successor rule or regulation promulgated under the Exchange Act.
e. Continuing Director. A "Continuing Director" shall mean a director of the Company who (i) is not an Acquiring Person or an Affiliate or Associate thereof, or a representative of an Acquiring Person or nominated for election by an Acquiring Person, and (ii) was either a member of the Board of Directors of the Company on the date of this Agreement or subsequently became a director of the Company and whose initial election or initial nomination for election by the Company's shareholders was approved by a majority of the Continuing Directors then on the Board of Directors of the Company.
f. Exchange Act. "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended.
g. Option Shares. "Option Shares" shall mean the Common Stock shares received upon exercise of the Option.
h. Transfer. "Transfer" (or any derivative thereof) means a direct or indirect assignment, sale, transfer, license, lease, pledge, encumbrance, hypothecation or execution, attachment or similar process.
2. TERM OF OPTION. The term of the Option shall expire at 12:00 midnight on the date set forth in the upper right hand corner on page 1 of this Agreement (the "Expiration Date" or "stated term"), except as such term may be otherwise shortened by the other provisions of the Plan or this Agreement.
3. EXERCISE OF OPTION.
a. Exercise. The Option shall become exercisable in increments as follows:
Date Upon Which Right Number of Shares To Purchase Accrues ---------------- ------------------- 4,166 August 6, 2004 4,167 November 6, 2004 4,167 February 6, 2005 4,166 May 6, 2005 4,167 August 6, 2005 4,167 November 6, 2005 4,166 February 6, 2006 4,167 May 6, 2006 4,167 August 6, 2006 4,166 November 6, 2006 4,167 February 6, 2007 4,167 May 6, 2007 |
Except as provided in the Plan, the Option shall not be exercisable unless the Optionee is, at the time of exercise, a director of the Company, and once the Option has become exercisable with respect to a certain number of shares as provided above, it shall thereafter be exercisable as to all of that number of shares, or as to any part thereof, until the expiration or termination of the Option. However, the Option may not be exercised as to less than 100 shares at any one time (or the remaining shares then purchasable under the Option, if less than 100 shares).
b. Adjustment. In the event there is any adjustment to the Common Stock pursuant to Section 9 of the Plan, the Board of Directors or Committee shall make such adjustment as it deems appropriate to the number of shares subject to the Option or to the exercise price listed above, or both. If a merger, consolidation, sale of shares, or similar transaction involving the Company, on the one hand, and one or more persons, on the other hand, with respect to the Company occurs, and, as a part of such transaction, shares of stock, other securities, cash or property shall be issuable or deliverable in exchange for Common Stock, then the Optionee shall be entitled to purchase or receive (in lieu of the Option Shares that the Optionee would otherwise be entitled to purchase or receive hereunder), the number of shares of stock, other securities, cash or property to which that number of shares of Common Stock would have been entitled in connection with such transaction (and, at an aggregate exercise price equal to the aggregate exercise price hereunder that would have been payable if that number of shares of Common Stock had been purchased on the exercise of the Option immediately before the consummation of the transaction).
c. Accelerated Vesting. The Option shall become fully exercisable (i) upon the occurrence of a Change of Control, if the Optionee is still a director of the Company on the date of the occurrence of the Change of Control or (ii) if the Optionee is removed from the Board of Directors of the Company by a vote of the shareholders other than for Cause. If either of such events occurs, the Option may be exercised at any time or times thereafter until the expiration or termination of the Option.
d. Method of Exercise. To exercise the Option with respect to any vested shares of Common Stock hereunder, the Optionee shall provide written notice (the "Exercise Notice") to the Company at its principal executive office. The Exercise Notice shall be deemed given when deposited in the U. S. mails, postage prepaid, addressed to the Company at its principal executive office, or if given other than by deposit in the U.S. mails, when delivered in person to an officer of the Company at that office. The date of exercise of the Option (the "Exercise Date") shall be the date of the postmark if the notice is mailed or the date received if the notice is delivered other than by mail. The Exercise Notice shall state the number of shares in respect of which the Option is being exercised and, if the shares for which the Option is being exercised are to be evidenced by more than one stock certificate, the denominations in which the stock certificates are to be issued. The Exercise Notice shall be signed by the Optionee and shall include the complete address of such person, together with such person's social security number. If the Option is exercised in full, the Optionee shall surrender this Agreement to the Company for cancellation. If the Option is exercised in part, the Optionee shall surrender this Agreement to the Company so that the Company may make appropriate notation hereon or cancel this Agreement and issue a new agreement representing the unexercised portion of the Option.
At the time of exercise, the Optionee shall pay to the Company the Option Price times the number of vested shares as to which the Option is being exercised. The Optionee shall make such payment by delivering (a) cash, (b) a certified cashier's check or (c) at the Committee's election, any other consideration that the Committee determines is consistent with the Plan and applicable law. If the shares to be purchased are covered by an effective registration statement under the Securities Act of 1933, as amended, the Option may be exercised by a broker-dealer acting on behalf of the Optionee if (a) the broker-dealer has received from the Optionee or the Company a fully- and duly-endorsed agreement evidencing such Option, together with instructions signed by the Optionee requesting the Company to deliver the shares of Common Stock subject to such Option to the broker-dealer on behalf of the Optionee and specifying the account into which such shares should be deposited, (b) adequate provision has been made with respect to the payment of any withholding taxes due upon such exercise, and (c) the broker-dealer and the Optionee have otherwise complied with Section 220.3(e)(4) of Regulation T, 12 CFR Part 220, or any successor provision.
The certificates for shares of Common Stock as to which the Option shall have been so exercised shall be registered in the name of the Optionee and shall be delivered to the Optionee at the address specified in the Exercise Notice. If applicable, the stock certificates shall contain an appropriate legend referencing the transfer restrictions noted in Subparagraph 3.d. An Option exercise shall be valid only if the Optionee makes payment or other arrangements relating to the withholding tax obligations discussed in Paragraph 11. In the event the person exercising the Option is a transferee of the Optionee by will or under the laws of descent and distribution, the Exercise Notice shall be accompanied by appropriate proof of the right of such transferee to exercise the Option.
4. WHO MAY EXERCISE OPTION. The Option shall be exercisable during the lifetime of the Optionee only by the Optionee. To the extent exercisable after the Optionee's death, the Option shall be exercised only by a person who has obtained the Optionee's rights under the Option by will or under the laws of descent and distribution.
5. TERMINATION OF OPTION. If the Optionee's directorship is terminated by a vote of the shareholders or directors for Cause, the Option shall automatically expire (and shall not thereafter be exercisable) simultaneously with such termination. If the Optionee's directorship terminates for any other reason, the Option shall be exercisable with respect to the shares that were vested as of the termination date until the first anniversary of the date that the Optionee ceased to be a director of the Company (or, if the remaining stated term of the Option is shorter, until 12:00 midnight on the Expiration Date). The Option shall not thereafter be exercisable.
6. NO RIGHTS AS SHAREHOLDER. Neither the Optionee nor any person claiming under or through the Optionee shall be or have any rights or privileges of a shareholder of the Company in respect of any of the shares issuable upon the exercise of the Option, unless and until certificates representing such shares shall have been issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company).
7. STATE AND FEDERAL SECURITIES REGULATION. No shares shall be issued by the Company upon the exercise of the Option unless and until any then-applicable requirements of state and federal laws
and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel. The Company may suspend for a reasonable period or periods the time during which the Option may be exercised if, in the opinion of the Company, such suspension is required to enable the Company to remain in compliance with regulatory requirements relating to the issuance of shares of Common Stock subject to the Option. The Option is subject to the requirement that, if at any time the Company shall determine, in its discretion, that the listing, registration or qualification of the shares of Common Stock subject to the Option upon any securities exchange or under any state or federal law, or the consent or approval of any government regulatory body, is necessary or desirable as a condition of, or in connection with, the granting or exercise of the Option or the issue or purchase of shares under the Option, the Option may not be exercised in whole or in part until such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company. The Company shall be under no obligation to effect or obtain any such listing, registration, qualification, consent or approval if the Company shall determine, in its discretion, that such action would not be in the best interest of the Company. The Company shall not be liable for damages due to a delay in the delivery or issuance of any stock certificates for any reason whatsoever, including, but not limited to, a delay caused by listing, registration or qualification of the shares of Common Stock subject to an option upon any securities exchange or under any federal or state law or the effecting or obtaining of any consent or approval of any governmental body with respect to the granting or exercise of the Option or the issue or purchase of shares under the Option.
8. MODIFICATION OF OPTIONS. At any time and from time-to-time, the Committee may execute an instrument providing for modification, extension or renewal of the Option, provided that no such modification, extension or renewal shall (i) impair the Option in any respect without the written consent of the holder of the Option or (ii) conflict with the provisions of Rule 16b-3 under the Exchange Act. Except as provided in the preceding sentence, no supplement, modification or amendment of this Agreement or waiver of any provision of this Agreement shall be binding unless executed in writing by all parties to this Agreement. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision of this Agreement (regardless of whether similar), nor shall any such waiver constitute a continuing waiver unless otherwise expressly provided.
9. CONTINUED DIRECTORSHIP NOT PRESUMED. Nothing in this Agreement, the Plan or any document describing it nor the grant of an option shall give the Optionee the right to continue as a director of the Company.
10. OPTION ISSUED PURSUANT TO PLAN. The Optionee accepts the Option herein subject to all the provisions of the Plan, which are incorporated herein, including the provisions that authorize the Committee to administer and interpret the Plan and provide that the Committee's determinations and interpretations with respect to the Plan are final and conclusive and binding on all persons affected thereby.
11. TAX WITHHOLDING. Any provision of this Agreement to the contrary notwithstanding, the Company may take such steps as it deems necessary or desirable for the withholding of any taxes that it is required by law or regulation of any governmental authority, federal, state or local, domestic or
foreign, to withhold in connection with any of the shares of Common Stock subject hereto.
12. NO LIABILITY OF OPTION. The Option is not liable for or subject to, in whole or in part, the debts, contracts, liabilities or torts of the Optionee nor shall it be subject to garnishment, attachment, execution, levy or other legal or equitable process.
13. NO ASSIGNMENT. The Option is not Transferable otherwise than by will or the laws of descent and distribution, and is exercisable during the Optionee's lifetime only by him or her. Without limiting the generality of the foregoing, the Option may not be Transferred (except as aforesaid), and shall not be subject to execution, attachment or similar process, without the prior written consent of the Company. Any attempted Transfer contrary to the provisions hereof shall be void and ineffective for all purposes.
14. GOVERNING LAW. This Agreement has been executed in, and shall be deemed to be performable in, Dallas, Dallas County, Texas. The parties agree that this Agreement shall be governed by and construed in accordance with the laws of the State of Texas (excluding its conflict of laws rules). The parties further agree that the courts of the State of Texas, and any courts whose jurisdiction is derivative on the jurisdiction of the courts of the State of Texas, shall have personal jurisdiction over all parties to this Agreement.
15. ENTIRE AGREEMENT. Except for the Plan, this Agreement constitutes the entire agreement between the parties pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements, representations and understandings of the parties. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the party to be charged therewith. No waiver of any of the provisions of this Agreement shall be deemed, or shall, constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver.
16. DUPLICATE ORIGINALS. Duplicate originals of this document shall be executed by both the Company and the Optionee, each of which shall retain one duplicate original.
17. NOTICE. Other than any Exercise Notice, any notice required or permitted to be given under the Plan or this Agreement shall be in writing and delivered in person or sent by registered or certified mail, return receipt requested, first-class postage prepaid, (i) if to the Optionee, at the address shown on the books and records of the Company or at the Optionee's place of employment, or (ii) if to the Company, at 2711 N. Haskell Avenue, Suite 2300, Dallas, Texas 75204-2960, Attention: Vice President Finance & Administration, or any other address that may be given by either party to the other party by notice pursuant to this Paragraph 17. Any notice other than any Exercise Notice, if sent by registered or certified mail, shall be deemed to have been given when received.
18. MISCELLANEOUS.
a. The Option herein is intended to be a nonqualified stock option under applicable tax laws, and it is not to be characterized or treated as an incentive stock option under such laws.
b. Subject to the limitations herein on the Transferability by the Optionee of the Option and any shares of Common Stock, this Agreement shall be binding upon and inure to the benefit of the representatives, executors, successors or beneficiaries of the parties hereto.
c. If any provision of this Agreement is declared or found to be illegal, unenforceable or void, in whole or in part, then the parties shall be relieved of all obligations arising under such provision, but only to the extent that it is illegal, unenforceable or void, it being the intent and agreement of the parties that this Agreement shall be deemed amended by modifying such provision to the extent necessary to make it legal and enforceable while preserving its intent or, if that is not possible, by substituting therefor another provision that is legal and enforceable and achieves the same objectives.
d. All section titles and captions in this Agreement are for convenience only, shall not be deemed part of this Agreement, and in no way shall define, limit, extend or describe the scope or intent of any provisions of this Agreement.
e. The parties shall execute all documents, provide all information and take or refrain from taking all actions as may be necessary or appropriate to achieve the purposes of this Agreement.
f. No failure by any party to insist upon the strict performance of any covenant, duty, agreement or condition of this Agreement or to exercise any right or remedy consequent upon a breach thereof shall constitute a waiver of any such breach or any other covenant, duty, agreement or condition.
g. In addition to all other rights or remedies available at law or in equity, the Company shall be entitled to injunctive and other equitable relief to prevent or enjoin any violation of the provisions of this Agreement.
ZIX CORPORATION
By: /s/ Bradley C. Almond ----------------------------- Bradley C. Almond Vice President Finance & Administration |
OPTIONEE:
/s/ Antonio R. Sanchez III ----------------------------- Antonio R. Sanchez III |
Exhibit 10.5
SERVICES AGREEMENT
Center:
Gold River
Address:
2377 Gold Meadow Way, Suite 100
City, State and Zip:
Gold River, CA 95670
SSN or Tax IDS:
Phone:
916-631-1500
Angela Presidio, Sales Manager
Contact Name: Michael Snipes
Fax: 916-631 -1515
Contact Name
Billing Address (if different from above):
Type of Business or Service: Computer Software
Persons authorized to charge to account: Michael Snipes
Referring Broker:
n/a
|
Real Estate Company Name: n/a | |
|
||
Program:
Full Office
|
Number of Offices: 1 |
Office Numbers:
11
682.00
Base Rent
250.00
Communication Package
105.00
1500 LD Minutes
Total: 1,037.00
Refundable Retainer: 1,364.00
|
Fixed Fee & Service Payment Date: 1 st of the Month |
Agreement Term: 12 Months
Start Date:
05/10/04
|
End Date: 05/31/05 |
Client acknowledges taking early occupancy of said Office Numbers on:
Occupancy Date: 05/10/04
This Agreement will automatically renew for the same period of time as listed in the Agreement Term (each, a Renewal Term) set forth above. On each Renewal Term, the fixed monthly fees and other fees applicable to this Agreement will automatically increase by 5 percent.
| If this Agreement is for less than Three (3) offices, written notice must be provided at least sixty (60) days prior to the Agreement End Date to cancel the renewal. | |||
| If this Agreement is for Three (3) or more offices written notice must be provided at least ninety (90) days prior to the Agreement End Date to cancel the renewal. |
I have read and understand the Agreement, including the terms and conditions on the reverse side and 1 agree to be bound by the Agreement terms and conditions.
TERMS AND CONDITIONS
1. | OFFICE ACCESS. As a client you have a license to use the office(s) assigned to you. You also have shared used of common areas in the center. Your office comes with standard office furniture. You have access to your office(s) twenty-four (24) hours a day, seven (7) days a week. Our building provides office cleaning, maintenance services, electric heating and air conditioning to the center during normal business hours as determined by the landlord for the building. We reserve the right to relocate you to another office in the center from time to time. If we exercise this right it will only be to an office of equal or larger size and configuration. This relocation is at our expense. We reserve the right to show the office(s) to prospective clients and will use reasonable efforts not to disrupt your business. |
2. | SERVICES. In addition to your office, we provide you with certain services on an as requested basis. The fee schedule for these services is available upon request. The fees are charged to your account and are payable on the service fee payment date listed on the reverse side of this agreement. You agree to pay all charges authorized by you or your employees. The fee schedule is updated from time to time. HQ Global Workplaces (HQ) and vendors designated by HQ are the only service providers authorized to provide services in the center. You agree that neither you nor your employees will solicit other clients of the center to provide any service provided by HQ or its designated vendors, or otherwise. In the event you default on your obligations under this agreement, you agree that HQ may cease to provide any and all services including telephone services without resort to legal process. | |||
3. | PAYMENTS. You agree to pay the fixed and additional service fees and all applicable sales or use taxes on the payment dates listed on the reverse side of this agreement. If you dispute any portion of the charges an your bill, you agree to pay the undisputed portion on the designated payment date. You agree that charges must be disputed within ninety (90) days or you waive your right to dispute such charges. You may be charged a late fee for any late payments. |
When you sign this agreement you are required to pay your fixed fee, set up fees and a refundable retainer. The refundable retainer will not be kept in a separate account from other funds of HQ and no interest will be paid to you on this amount. The refundable retainer may be applied to outstanding charges at any time at our discretion. We have the right to require that you replace retainer funds that we apply to your charges. At the end of the term of this agreement, if you have satisfied all of your payment obligations, we will refund you this retainer within forty-five (45) days.
4. | OUR LIMITATION OF LIABILITY. You acknowledge that due to the imperfect nature of verbal, written and electronic communications, neither HQ nor HQs landlord or any of their respective officers, directors, employees, shareholders, partners, agents or representatives shall be responsible for damages, direct or consequential, that may result from the failure of HQ to furnish any service. Including but not limited to the service of conveying messages, communications and other utility or services. Your sole remedy and HQs sole obligation for any failure to render any service, any error or omission, or any delay or interruption of any service, is limited to an adjustment to your bill in an amount equal to the charge for such service for the period during which the failure, delay or interruption continues. |
WITH THE SOLE EXCEPTION OF THE REMEDY DESCRIBED ABOVE, CLIENT EXPRESSLY AND SPECIFICALLY AGREES TO WAIVE, AND AGREES NOT TO MAKE, ANY CLAIM FOR DAMAGES, DIRECT OR CONSEQUENTIAL, INCLUDING WITH RESPECT TO LOST BUSINESS OR PROFITS, ARISING OUT OF ANY FAILURE TO FURNISH ANY SERVICE, ANY ERROR OR OMISSION WITH RESPECT THERETO, OR ANY DELAY OR INTERRUPTION OF SERVICES. HQ DISCLAIMS ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.
5. | LICENSE AGREEMENT. THIS AGREEMENT IS NOT A LEASE OR ANY OTHER INTEREST IN REAL PROPERTY. IT IS A CONTRACTUAL ARRANGEMENT THAT CREATES A REVOCABLE LICENSE. We retain legal possession and control of the center and the office assigned to you. Our obligation to provide you space and services is subject to the terms of our lease with the building. This agreement terminates simultaneously with the termination of our lease or the termination of the operation of our center for any reason. As our client you do not have any rights under our lease with our landlord. When this agreement is terminated because the term has expired or otherwise, your license to occupy the center is revoked. You agree to remove your personal property and leave the office as of the date of termination. We are not responsible for property left in the office after termination. |
6. | DAMAGES AND INSURANCE. You are responsible for any damage you cause to the center or your office(s) beyond normal wear and tear. We have the right to inspect the condition of the office from time to time and make any necessary repairs. |
You are responsible for insuring your personal property against all risks. You have the risk of loss with respect to any of your personal property. You agree to waive any right of recovery against HQ, its directors, officers and employees for any damage or loss to your property under your control. All property in your office(s) is understood to be under your control.
7. | DEFAULT. You are in default under this agreement if; 1) you fail to abide by the rules and regulations of the center, a copy of which has been provided to you; 2) you do not pay your fees on the designated payment date and after written notice of this failure to pay you do not pay within five (5) days; or 3) you do not comply with the terms of this agreement. If the default is unrelated to payment you will be given written notice of the default and you will have ten (10) days to correct the default. |
8. | TERMINATION. You have the right to terminate this agreement early; 1) if your mail or telecommunications service or access to the office(s) is out for a period of ten (10) concurrent business days; or 2) in connection with a transfer to another center in the HQ network. |
HQ has the right to terminate this agreement early; 1) if you fail to correct a default or the default cannot be corrected; 2) without opportunity to cure if you repeatedly default under the agreement; or 3) if you use the center for any illegal operations or purposes.
9. | RESTRICTION ON HIRING. Our employees are an essential part of our ability to deliver our services. You acknowledge this and agree that, during the term of your agreement and for six (6) months afterward, you will not hire any of our employees. If you do hire one of our employees, you agree that actual damages would be difficult to determine and therefore you agree to pay liquidated damages in the amount of one-half of the annual base salary of the employee you hire. You agree that this liquidated damage amount is fair and reasonable. |
10. | BUSINESS CONTINUATION. Based on Clients selection below, upon expiration, cancellation or termination of this Services Agreement, for any reason other than default, HQ will: (CHECK ONE ONLY) |
x For a period of 3 months (2 month minimum), forward Clients mail on a once weekly basis to one single designated domestic address. Clients assigned telephone number will remain active and calls will automatically direct to voicemail. Client will have unlimited access to voicemail during the Business Continuation term. Client must pay a monthly Business Continuation fee of $50 per month, plus the cost of all postage associated with the re-mailing service.
o Refuse, discard or destroy any mail or packages addressed to Client and delivered to Facility. Clients assigned telephone number will be de-activated and all inbound calls to that number will receive an announcement that the number is no longer in service. Client hereby releases and forever discharges the HQ Parties for any claim, damage or liability based on failure to deliver any mail, package or voice messages after the termination of this Services Agreement.
Payment for Business Continuation is due in upon expiration, cancellation or termination of this Services Agreement and payable in full, in advance for the selected number of months. Charges for postage associated with mail forwarding are due upon invoicing. Payment must be made by execution of Credit Card Authorization.
11. | MISCELLANEOUS. |
A. | All notices are to be in writing and may be given by registered or certified mail, postage prepaid, overnight mail service or hand delivered with proof of delivery, addressed to HQ or client at the address listed on the reverse side of this agreement. | |||
B. | You acknowledge that HQ will comply with the U.S. Postal Service regulations regarding client mail. Upon termination of this agreement, you must notify all parties with whom you do business of your change of address. You agree not to file a change of address form with the postal service. | |||
C. | In the event a dispute arises under this agreement you agree to submit the dispute to mediation. If mediation does not resolve the dispute, you agree that the matter will be submitted to arbitration pursuant to the procedure established by the American Arbitration Association in the metropolitan area in which the center is located. The decision of the arbitrator will be binding on the parties. The non-prevailing party as determined by the arbitrator shall pay the prevailing parties attorneys fees and costs of the arbitration. Furthermore, if a court decision prevents or HQ elects not to submit this matter to arbitration, then the non-prevailing party as determined by the court shall pay the prevailing parties reasonable attorneys fees and costs. Nothing in this paragraph will prohibit HQ from seeking equitable relief including without limitation any action for removal of the client from the center after the license has been terminated or revoked. | |||
D. | This agreement is governed by the laws of the state in which the center is located. | |||
E. | This agreement is the entire agreement between you and HQ. It supercedes all prior agreements. | |||
F. | Client may not assign this agreement without HQs prior written consent, which will not be unreasonably withheld. |
BY CLIENT : /s/ Brad Almond
|
|
Authorized Signature
|
|
Brad Almond CFO
|
5/7/04
|
Print Name and Title | Date |
BY HQ GLOBAL WORKPLACES, INC.
/s/ Angela Presidio
|
|
Authorized Signature
|
|
Angela Presidio, Sales
Manager
|
5/24/04
|
Print Name and Title | Date |
HQ Global Workplace Services Agreement January 6, 2004
EXHIBIT 31.1
ZIX CORPORATION
JUNE 30, 2004
CEO CERTIFICATION
I, John A. Ryan, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Zix Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
(b)
[intentionally omitted]
(c)
Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrants internal control
over financial reporting that occurred during the registrants most recent
fiscal quarter (the registrants fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial
reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | |||
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: August 9, 2004 | /s/ John A. Ryan | |||
|
||||
|
Name: John A. Ryan | |||
|
Title: Chairman and Chief Executive Officer |
EXHIBIT 31.2
ZIX CORPORATION
JUNE 30, 2004
CFO CERTIFICATION
I, Bradley C. Almond, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Zix Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
5. The registrants other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent functions):
(a)
Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
(b)
[intentionally omitted]
(c)
Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrants internal control
over financial reporting that occurred during the registrants most recent
fiscal quarter (the registrants fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial
reporting; and
(a)
All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date:
August 9, 2004
|
/s/ Bradley C. Almond | |||
|
|
|||
|
Name: | Bradley C. Almond | ||
|
Title: | Vice President, Chief Financial Officer and Treasurer |
EXHIBIT 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
In connection with the Quarterly Report of Zix Corporation (the Company)
on Form 10-Q for the quarterly period ended June 30, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, John
A. Ryan, Chairman and Chief Executive Officer of the Company, certify to the
best of my knowledge and in my capacity as an officer of the Company, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
IN WITNESS WHEREOF, the undersigned has executed this Certificate,
effective as of August 9, 2004.
Note: A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
1.
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
the Company as of the dates and for the periods expressed in the Report.
/s/ John A. Ryan
Name: John A. Ryan
Title: Chairman and Chief Executive Officer
EXHIBIT 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
In connection with the Quarterly Report of Zix Corporation (the Company)
on Form 10-Q for the quarterly period ended June 30, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the Report), I,
Bradley C. Almond, Vice President, Chief Financial Officer, and Treasurer of
the Company, certify to the best of my knowledge and in my capacity as an
officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:
IN WITNESS WHEREOF, the undersigned has executed this Certificate,
effective as of August 9, 2004.
Note: A signed original of this written statement required by Section 906 or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
3.
The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and
4.
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of
the Company as of the dates and for the periods expressed in the Report.
/s/ Bradley C. Almond
Name: Bradley C. Almond
Title: Vice President, Chief Financial
Officer, and Treasurer